| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1001 |
OC-0171: Multiparametric MRI margin characterization for focal brachytherapy in low-grade prostate cancer
|
Ken, S.
|
|
2017
|
123 |
S1 |
p. S87-S88
2 p.
|
artikel
|
| 1002 |
OC-0182: 2nd breast conserving therapy with interstitial BT vs mastectomy for treatment of local recurrences
|
Smanykó, V.
|
|
2017
|
123 |
S1 |
p. S93-
1 p.
|
artikel
|
| 1003 |
OC-0448: Near real-time automated dose restoration in IMPT to compensate for daily tissue density variations
|
Jagt, T.
|
|
2017
|
123 |
S1 |
p. S238-
1 p.
|
artikel
|
| 1004 |
OC-0429: Neoadjuvant chemoradiotherapy or 5x5 Gy followed by chemotherapy in rectal cancer: the RAPIDO trial
|
Marijnen, C.
|
|
2017
|
123 |
S1 |
p. S227-S228
2 p.
|
artikel
|
| 1005 |
OC-0364: Nomogram for predicting maculopathy in patients treated with Ru106 brachytherapy for uveal melanoma
|
Tagliaferri, L.
|
|
2017
|
123 |
S1 |
p. S195-S196
2 p.
|
artikel
|
| 1006 |
OC-0080: Normal tissue toxicity and in vivo dose-equivalence of synchroton radiotherapy modalities
|
Smyth, L.
|
|
2017
|
123 |
S1 |
p. S41-
1 p.
|
artikel
|
| 1007 |
OC-0082: Novel Valencia-type skin applicators: Dosimetry and implementation of a TG-43 hybrid technique
|
Baltas, D.
|
|
2017
|
123 |
S1 |
p. S42-
1 p.
|
artikel
|
| 1008 |
OC-0259: Online quantitative imaging on the MR-Linac
|
Koetsveld, F.
|
|
2017
|
123 |
S1 |
p. S132-S133
2 p.
|
artikel
|
| 1009 |
OC-0163: Online workflow for the First-in-Man study on bone metastases at the MRI-linear accelerator
|
Meijers, L.T.C.
|
|
2017
|
123 |
S1 |
p. S83-S84
2 p.
|
artikel
|
| 1010 |
OC-0162: Optimizing sequences for MRI-guided radiotherapy in cranial and head and neck regions
|
Fung, W.W.K.
|
|
2017
|
123 |
S1 |
p. S83-
1 p.
|
artikel
|
| 1011 |
OC-0465: Organ preservation for rectal cancer: the GRECCAR 2 randomized phase III trial
|
Vendrely, V.
|
|
2017
|
123 |
S1 |
p. S248-
1 p.
|
artikel
|
| 1012 |
OC-0124: Outcomes of concurrent chemo-radiotherapy in elderly patients with advanced bladder cancer
|
Christodoulou, M.
|
|
2017
|
123 |
S1 |
p. S57-S58
2 p.
|
artikel
|
| 1013 |
OC-0444: Pareto-optimal plans as ground truth to validate a commercial knowledge-based DVH-prediction system
|
Cagni, E.
|
|
2017
|
123 |
S1 |
p. S235-S236
2 p.
|
artikel
|
| 1014 |
OC-0128: Patient-reported outcome in the prostate HYPRO trial: gastrointestinal toxicity
|
Heemsbergen, W.
|
|
2017
|
123 |
S1 |
p. S60-S61
2 p.
|
artikel
|
| 1015 |
OC-0081: Patient Safety Is Improved With An Extensive Incident Learning System—9 Years Of Clinical Evidence
|
Deufel, C.
|
|
2017
|
123 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 1016 |
OC-0161: patient tolerance of stereotactic MR-guided adaptive radiation therapy: an assessment using PRO’s
|
Bakker, R.
|
|
2017
|
123 |
S1 |
p. S82-S83
2 p.
|
artikel
|
| 1017 |
OC-0038: Patterns in ano-rectal dose maps and the risk of late toxicity after prostate radiotherapy
|
Onjukka, E.
|
|
2017
|
123 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 1018 |
OC-0086: Perioperative interstitial high-dose-rate (HDR) brachytherapy for the treatment of recurrent keloids
|
Jiang, P.
|
|
2017
|
123 |
S1 |
p. S44-
1 p.
|
artikel
|
| 1019 |
OC-0524: Phase II trial on SBRT for Liver Metastases: Long-term outcomes and prognostic factors of survival
|
Comito, T.
|
|
2017
|
123 |
S1 |
p. S277-S278
2 p.
|
artikel
|
| 1020 |
OC-0052: Physician assessed and patient reported bladder morbidity after RCHT and IGABT for cervical cancer
|
Fokdal, L.U.
|
|
2017
|
123 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 1021 |
OC-0053: Physician assessed and patient reported limb edema after RCHT + IGABT for cervical cancer (EMBRACE)
|
Najjari Jamal, D.
|
|
2017
|
123 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 1022 |
OC-0368: Postoperative vaginal brachytherapy: a quality assurance dummy-run procedure in the PORTEC-4 trial
|
Nout, R.
|
|
2017
|
123 |
S1 |
p. S198-
1 p.
|
artikel
|
| 1023 |
OC-0255: Practical use of principal component analysis in radiotherapy planning
|
Christophides, D.
|
|
2017
|
123 |
S1 |
p. S129-S130
2 p.
|
artikel
|
| 1024 |
OC-0362: Precision IORT - image guided IORT including online CBCT based Monte Carlo treatment planning
|
Schneider, F.
|
|
2017
|
123 |
S1 |
p. S194-S195
2 p.
|
artikel
|
| 1025 |
OC-0427: Prediction models in rectal cancer: an update of a pooled analysis of 3770 randomized patients
|
Valentini, V.
|
|
2017
|
123 |
S1 |
p. S226-
1 p.
|
artikel
|
| 1026 |
OC-0349: Prediction of GTV median dose differences benefit Monte Carlo re-prescription in lung SBRT
|
Dechambre, D.
|
|
2017
|
123 |
S1 |
p. S185-
1 p.
|
artikel
|
| 1027 |
OC-0041: Predictors of asymptomatic radiation induced vascular damage to infradiaphragmatic vessels
|
Cella, L.
|
|
2017
|
123 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 1028 |
OC-0487: Pre-treatment characteristics can predict anatomical changes occurring during RT in lung cancer
|
Hoffmann, L.
|
|
2017
|
123 |
S1 |
p. S258-S259
2 p.
|
artikel
|
| 1029 |
OC-0445: Probabilistic optimization of the dose coverage – applied to treatment planning of cervical cancer
|
Tilly, D.
|
|
2017
|
123 |
S1 |
p. S236-
1 p.
|
artikel
|
| 1030 |
OC-0333: Prognostic impact of HPV and smoking in RT of oropharyngeal cancer: the MARCH-HPV project
|
Lassen, P.
|
|
2017
|
123 |
S1 |
p. S175-S176
2 p.
|
artikel
|
| 1031 |
OC-0400: Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers
|
Ou, D.
|
|
2017
|
123 |
S1 |
p. S213-
1 p.
|
artikel
|
| 1032 |
OC-0300: Proof of tumor position during SBRT delivery using (limited-arc) CBCT imaging
|
Hazelaar, C.
|
|
2017
|
123 |
S1 |
p. S154-S155
2 p.
|
artikel
|
| 1033 |
OC-0334: Prospective MR assessment of dose-response kinetics of non-target muscles in head and neck cancer
|
Mohamed, A.S.R.
|
|
2017
|
123 |
S1 |
p. S176-
1 p.
|
artikel
|
| 1034 |
OC-0180: Prospective study of APBI With Multicatheter Brachytherapy in Local Relapses of Breast Cancer
|
Villafranca Iturre, E.
|
|
2017
|
123 |
S1 |
p. S92-
1 p.
|
artikel
|
| 1035 |
OC-0254: Prospective validation of independent DVH prediction for QA of automatic treatment planning
|
Wang, Y.
|
|
2017
|
123 |
S1 |
p. S128-S129
2 p.
|
artikel
|
| 1036 |
OC-0273: Prostate brachytherapy in African-Caribbean patients: A retrospective analysis of 370 cases
|
Atallah, V.
|
|
2017
|
123 |
S1 |
p. S140-S141
2 p.
|
artikel
|
| 1037 |
OC-0130: Prostatic sarcomas: a large multicentric Rare Cancer Network study
|
De Bari, B.
|
|
2017
|
123 |
S1 |
p. S61-S62
2 p.
|
artikel
|
| 1038 |
OC-0246: Proton minibeam radiation therapy spares normal rat brain
|
Prezado, Y.
|
|
2017
|
123 |
S1 |
p. S124-S125
2 p.
|
artikel
|
| 1039 |
OC-0154: Proton therapy patient selection for oropharyngeal cancer patients: the impact of treatment accuracy
|
Hoogeman, M.
|
|
2017
|
123 |
S1 |
p. S77-S78
2 p.
|
artikel
|
| 1040 |
OC-0532: QA of stereotactic radiotherapy combined with electromagnetic MLC tracking by a silicon detector
|
Petasecca, M.
|
|
2017
|
123 |
S1 |
p. S282-
1 p.
|
artikel
|
| 1041 |
OC-0270: QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction:phase II trial
|
Gomez-Iturriaga, A.
|
|
2017
|
123 |
S1 |
p. S139-S140
2 p.
|
artikel
|
| 1042 |
OC-0491: Quality assurance of a novel table mounted imaging device integrated in a patient positioning system
|
Utz, A.
|
|
2017
|
123 |
S1 |
p. S261-S262
2 p.
|
artikel
|
| 1043 |
OC-0526: Quality of life after SBRT in bone metastases: analysis from the prospective PRESENT cohort
|
Fanetti, G.
|
|
2017
|
123 |
S1 |
p. S278-S279
2 p.
|
artikel
|
| 1044 |
OC-0514: radiation necrosis after proton beam therapy - when and where does it happen?
|
Harrabi, S.
|
|
2017
|
123 |
S1 |
p. S271-
1 p.
|
artikel
|
| 1045 |
OC-0513: Radiation necrosis following stereotactic RT and immunotherapy for melanoma brain metastases
|
Kaidar-Person, O.
|
|
2017
|
123 |
S1 |
p. S271-
1 p.
|
artikel
|
| 1046 |
OC-0515: Radiation necrosis in children with brain tumours treated with pencil beam scanning proton therapy
|
Bojaxhiu, B.
|
|
2017
|
123 |
S1 |
p. S271-S272
2 p.
|
artikel
|
| 1047 |
OC-0160: Radiomics Features Harmonization for CT and CBCT in Rectal Cancer
|
Luo, R.
|
|
2017
|
123 |
S1 |
p. S81-S82
2 p.
|
artikel
|
| 1048 |
OC-0304: Real-time gamma evaluations of motion induced dose errors as QA of liver SBRT tumour tracking
|
Ravkilde, T.
|
|
2017
|
123 |
S1 |
p. S157-S158
2 p.
|
artikel
|
| 1049 |
OC-0278: Red-emitting inorganic scintillation detectors to verify HDR brachytherapy treatments in real time
|
Kertzscher, G.
|
|
2017
|
123 |
S1 |
p. S144-
1 p.
|
artikel
|
| 1050 |
OC-0348: Reducing the dosimetric impact of variable gas volume in the abdomen during RT of esophageal cancer
|
Jin, P.
|
|
2017
|
123 |
S1 |
p. S184-S185
2 p.
|
artikel
|
| 1051 |
OC-0060: Reference dosimetry of proton pencil beams based on dose-area product
|
Gomà, C.
|
|
2017
|
123 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 1052 |
OC-0125: Relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 trial
|
Ghadjar, P.
|
|
2017
|
123 |
S1 |
p. S58-S59
2 p.
|
artikel
|
| 1053 |
OC-0279: Removing the blindfold - a new take on real-time brachytherapy dosimetry
|
Johansen, J.
|
|
2017
|
123 |
S1 |
p. S144-S145
2 p.
|
artikel
|
| 1054 |
OC-0084: Results of excision and 13 Gy single dose HDR brachytherapy for keloids
|
Hafkamp, C.
|
|
2017
|
123 |
S1 |
p. S43-
1 p.
|
artikel
|
| 1055 |
OC-0443: Robust optimization of VMAT in head and neck patients
|
Wagenaar, D.
|
|
2017
|
123 |
S1 |
p. S234-S235
2 p.
|
artikel
|
| 1056 |
OC-0363: Ruthenium-106 brachytherapy for iris and choroidal body melanomas
|
Peters, F.P.
|
|
2017
|
123 |
S1 |
p. S195-
1 p.
|
artikel
|
| 1057 |
OC-0175: Salvage HDR-BT in prostate local recurrence after radiation therapy: Retrospective analysis
|
De la Pinta, C.
|
|
2017
|
123 |
S1 |
p. S89-S90
2 p.
|
artikel
|
| 1058 |
OC-0174: Salvage LDR-brachytherapy for recurrent prostate cancer: results from a single institution
|
Magrini, S.
|
|
2017
|
123 |
S1 |
p. S89-
1 p.
|
artikel
|
| 1059 |
OC-0523: SBRT for oligo-metastatic liver disease–effect of chemotherapy and histology on local tumor control
|
Klement, R.
|
|
2017
|
123 |
S1 |
p. S277-
1 p.
|
artikel
|
| 1060 |
OC-0424: SBRT for Primary Liver Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis
|
Brunner, T.
|
|
2017
|
123 |
S1 |
p. S224-
1 p.
|
artikel
|
| 1061 |
OC-0437: Scatter imaging: promising modality for image guided ablation radiotherapy for lung cancer patients
|
Chu, J.
|
|
2017
|
123 |
S1 |
p. S230-
1 p.
|
artikel
|
| 1062 |
OC-0153: Sensitivity evaluation of prompt γ-ray based range verification with a slit camera
|
Nenoff, L.
|
|
2017
|
123 |
S1 |
p. S76-S77
2 p.
|
artikel
|
| 1063 |
OC-0164: Set-up reproducibility on an MR-Linac
|
Betgen, A.
|
|
2017
|
123 |
S1 |
p. S84-
1 p.
|
artikel
|
| 1064 |
OC-0073: Shoulder girdle impairment evaluation in breast cancer patients undergoing surgery and radiotherapy
|
Smaniotto, D.
|
|
2017
|
123 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 1065 |
OC-0075: Simple spatula improves the geometrical accuracy of a cranial mask for brain tumor radiotherapy
|
Wolffs, N.
|
|
2017
|
123 |
S1 |
p. S39-
1 p.
|
artikel
|
| 1066 |
OC-0269: Single Dose Compared to Fractionated High-Dose Rate Brachytherapy for Localised Prostate Cancer
|
Hoskin, P.
|
|
2017
|
123 |
S1 |
p. S139-
1 p.
|
artikel
|
| 1067 |
OC-0316: Single dose external beam preoperative radiotherapy in breast cancer: experience and guidelines
|
Charaghvandi, K.R.
|
|
2017
|
123 |
S1 |
p. S164-
1 p.
|
artikel
|
| 1068 |
OC-0263: Single vs. multi-atlas auto-segmentation for prostate RT: Comparison of two commercial systems
|
Gulyban, A.
|
|
2017
|
123 |
S1 |
p. S135-S136
2 p.
|
artikel
|
| 1069 |
OC-0453: Stereotactic radiosurgery for multiple brain metastases: Results of multi-centre benchmark studies
|
Eaton, D.J.
|
|
2017
|
123 |
S1 |
p. S241-S242
2 p.
|
artikel
|
| 1070 |
OC-0544: Stereotactic radiotherapy in elderly patients: age, survival and performance status
|
Monroy Anton, J.L.
|
|
2017
|
123 |
S1 |
p. S289-S290
2 p.
|
artikel
|
| 1071 |
OC-0243: Submicron focused proton irradiation - understanding the RBE of heavy ion irradiation
|
Schmid, T.E.
|
|
2017
|
123 |
S1 |
p. S122-S123
2 p.
|
artikel
|
| 1072 |
OC-0428: Surgical time to increase pCR in rectal cancer: pooled set of 3078 patients from 7 randomized trials
|
Chiloiro, G.
|
|
2017
|
123 |
S1 |
p. S226-S227
2 p.
|
artikel
|
| 1073 |
OC-0301: Target position uncertainty during visually guided breathhold radiotherapy in locally advanced NSCLC
|
Scherman Rydhög, J.
|
|
2017
|
123 |
S1 |
p. S155-S156
2 p.
|
artikel
|
| 1074 |
OC-0275: Testing an MR-compatible afterloader for MR-based source tracking in MRI guided HDR brachytherapy
|
Beld, E.
|
|
2017
|
123 |
S1 |
p. S141-S142
2 p.
|
artikel
|
| 1075 |
OC-0271: The clinical outcome after high dose rate brachytherapy as monotherapy in localized prostate cancer
|
Kariya, S.
|
|
2017
|
123 |
S1 |
p. S140-
1 p.
|
artikel
|
| 1076 |
OC-0227: The heterogeneous multiscale model for efficient computation of microscopic dose metrics
|
Martinov, M.
|
|
2017
|
123 |
S1 |
p. S113-
1 p.
|
artikel
|
| 1077 |
OC-0438: The impact of a 1.5T MR-Linac fringe field on neighbouring linear accelerators
|
Perik, T.
|
|
2017
|
123 |
S1 |
p. S230-S231
2 p.
|
artikel
|
| 1078 |
OC-0531: The influence of detector resolution on pre-treatment quality assurance in SBRT
|
Bruschi, A.
|
|
2017
|
123 |
S1 |
p. S281-S282
2 p.
|
artikel
|
| 1079 |
OC-0242: The oxygen enhancement ratio for carbon ions is smaller than for photons in R3327-HI prostate tumors
|
Glowa, C.
|
|
2017
|
123 |
S1 |
p. S122-
1 p.
|
artikel
|
| 1080 |
OC-0521: The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study
|
Triggiani, L.
|
|
2017
|
123 |
S1 |
p. S276-
1 p.
|
artikel
|
| 1081 |
OC-0231: The suitability of radiochromic film in 0.35T magnetic field CO-60 compared with conventional 6MV
|
Barten, D.L.J.
|
|
2017
|
123 |
S1 |
p. S115-S116
2 p.
|
artikel
|
| 1082 |
OC-0488: Thoracic tumor treatment course assessment based on 4D dose accumulation for scanned proton therapy
|
Meijers, A.
|
|
2017
|
123 |
S1 |
p. S259-
1 p.
|
artikel
|
| 1083 |
OC-0276: Toward adaptive MR-guided HDR prostate brachytherapy - Simulation study based on anatomy movements
|
Borot de Battisti, M.
|
|
2017
|
123 |
S1 |
p. S142-S143
2 p.
|
artikel
|
| 1084 |
OC-0226: Towards consistency of TPS dose calculations: converting dose to medium to dose to water
|
Reynaert, N.
|
|
2017
|
123 |
S1 |
p. S112-S113
2 p.
|
artikel
|
| 1085 |
OC-0165: TPUS vs CBCT: comparison of daily inter-modality derived setup shifts for prostate radiotherapy
|
Pang, E.P.P.
|
|
2017
|
123 |
S1 |
p. S84-S85
2 p.
|
artikel
|
| 1086 |
OC-0376: Trajectory Optimization in Radiotherapy Using Sectioning (TORUS)
|
Locke, C.
|
|
2017
|
123 |
S1 |
p. S202-S203
2 p.
|
artikel
|
| 1087 |
OC-0399: Transcriptome analyses of the radiation response in HNSCC cells with different radiation sensitivity
|
Heß, J.
|
|
2017
|
123 |
S1 |
p. S212-S213
2 p.
|
artikel
|
| 1088 |
OC-0439: Treating patients with Dynamic Wave Arc: first clinical experience
|
Burghelea, M.
|
|
2017
|
123 |
S1 |
p. S231-S232
2 p.
|
artikel
|
| 1089 |
OC-0230: Treatment log files as a tool to identify inaccuracies in scanned proton beam delivery and planning
|
Belosi, M.
|
|
2017
|
123 |
S1 |
p. S115-
1 p.
|
artikel
|
| 1090 |
OC-0357: Treatment planning dosimetry accuracy in 192Ir HDR brachytherapy of lip carcinoma
|
Papagiannis, P.
|
|
2017
|
123 |
S1 |
p. S190-S191
2 p.
|
artikel
|
| 1091 |
OC-0039: Unique sparing of spatial memory in mice after whole brain irradiation with dose rates above 100Gy/s
|
Petersson, K.
|
|
2017
|
123 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 1092 |
OC-0140: Updating QUANTEC and clinically adjusted QUANTEC models for pneumonitis at external validation
|
Van Der Schaaf, A.
|
|
2017
|
123 |
S1 |
p. S68-
1 p.
|
artikel
|
| 1093 |
OC-0256: Using a knowledge-based planning solution to select patients for proton therapy
|
Delaney, A.
|
|
2017
|
123 |
S1 |
p. S130-
1 p.
|
artikel
|
| 1094 |
OC-0464: Validation of a fully automatic real-time liver motion monitoring method on a conventional linac
|
Bertholet, J.
|
|
2017
|
123 |
S1 |
p. S247-
1 p.
|
artikel
|
| 1095 |
OC-0141: Validation of dose-sensitive heart regions affecting survival in SABR lung cancer patients
|
McWilliam, A.
|
|
2017
|
123 |
S1 |
p. S68-S69
2 p.
|
artikel
|
| 1096 |
OC-0305: Validation of Dynamic Treatment-Couch Tracking for Prostate SBRT
|
Ehrbar, S.
|
|
2017
|
123 |
S1 |
p. S158-
1 p.
|
artikel
|
| 1097 |
OC-0340: Validation of HU to mass density conversion curve: Proton range measurements in animal tissues
|
Góra, J.
|
|
2017
|
123 |
S1 |
p. S178-S179
2 p.
|
artikel
|
| 1098 |
OC-0040: Validation of prospective electronic toxicity registration to audit dose constraints
|
Janssen, T.M.
|
|
2017
|
123 |
S1 |
p. S16-
1 p.
|
artikel
|
| 1099 |
OC-0484: Variability of breathing-induced tumour motion: 4DCT – a source of misguiding information?
|
Dhont, J.
|
|
2017
|
123 |
S1 |
p. S256-S257
2 p.
|
artikel
|
| 1100 |
OC-0489: Variation in bladder volume and associated spatial dose metrics in prostate and pelvic radiotherapy
|
Casares-Magaz, O.
|
|
2017
|
123 |
S1 |
p. S260-
1 p.
|
artikel
|
| 1101 |
OC-0546: Video Launching during Irradiation – an alternative to anesthesia in pediatric patients?
|
Palhetinha Aguas, C.
|
|
2017
|
123 |
S1 |
p. S290-S291
2 p.
|
artikel
|
| 1102 |
OC-0268: Volumetric comparison between PET/CT and CT simulation for target delineation in esophageal cancer
|
Jimenez-Jimenez, E.
|
|
2017
|
123 |
S1 |
p. S138-S139
2 p.
|
artikel
|
| 1103 |
OC-0339: Water calorimetry in a pulsed PBS proton beam
|
Rossomme, S.
|
|
2017
|
123 |
S1 |
p. S177-S178
2 p.
|
artikel
|
| 1104 |
OC-0313: What is the effect of axillary treatment on patient reported outcomes in breast cancer patients?
|
Gregorowitsch, M.L.
|
|
2017
|
123 |
S1 |
p. S161-S162
2 p.
|
artikel
|
| 1105 |
OC-0355: Which anatomical changes in Head & Neck cancer lead to Repeat CT/planning?
|
Van Beek, S.
|
|
2017
|
123 |
S1 |
p. S188-S189
2 p.
|
artikel
|
| 1106 |
OC-0129: 5-year safety, efficacy & quality of life outcomes from multi-center SBRT trial for prostate cancer
|
Meier, R.
|
|
2017
|
123 |
S1 |
p. S61-
1 p.
|
artikel
|
| 1107 |
P-1113: Helical Tomotherapy and altered fractionation in the treatment of Glioblastoma
|
Caruso, C.
|
|
2017
|
123 |
S1 |
p. S608-S609
2 p.
|
artikel
|
| 1108 |
PO-1003: A analysis of safety of whole brain radiotherapy with Hippocampus avoidance in brain metastasis
|
Han, Y.
|
|
2017
|
123 |
S1 |
p. S553-
1 p.
|
artikel
|
| 1109 |
PO-0810: Absolute dose pre-treatment Portal Dosimetry using the Varian MAASTRO implementation
|
Taborda, A.
|
|
2017
|
123 |
S1 |
p. S433-S434
2 p.
|
artikel
|
| 1110 |
PO-0793: Absorbed dose distributions of ruthenium ophthalmic plaques measured in water with radiochromic film
|
Hermida-López, M.
|
|
2017
|
123 |
S1 |
p. S421-S422
2 p.
|
artikel
|
| 1111 |
PO-0969: Accelerated fractionation should start early for laryngeal/ hypopharyngeal cancer
|
Terhaard, C.
|
|
2017
|
123 |
S1 |
p. S535-
1 p.
|
artikel
|
| 1112 |
PO-0625: Accelerated-hypofractionated IMRT plus Temozolomide in Glioblastoma:a phase I dose-escalation study
|
Ferro, M.
|
|
2017
|
123 |
S1 |
p. S327-
1 p.
|
artikel
|
| 1113 |
PO-0996: Accuracy of an optical surface monitoring device to reduce daily imaging of breast cancer patients
|
Sharpe, J.
|
|
2017
|
123 |
S1 |
p. S549-
1 p.
|
artikel
|
| 1114 |
PO-0864: Accuracy of fiducial based correction of target motion in prostate SBRT treatments
|
Viren, T.
|
|
2017
|
123 |
S1 |
p. S470-S471
2 p.
|
artikel
|
| 1115 |
PO-0781: A characterisation of EBT3 Gafchromic film for relative and absolute dosimetry
|
Billas, I.
|
|
2017
|
123 |
S1 |
p. S414-
1 p.
|
artikel
|
| 1116 |
PO-0787: A compact and complete model for Bragg peak degradation in lung tissue
|
Dal Bello, R.
|
|
2017
|
123 |
S1 |
p. S417-S418
2 p.
|
artikel
|
| 1117 |
PO-0727: Acute intestinal toxicity after whole-pelvis IMRT for prostate cancer from the patient’s perspective
|
Noris Chiorda, B.
|
|
2017
|
123 |
S1 |
p. S381-S382
2 p.
|
artikel
|
| 1118 |
PO-0809: A 3D polymer gel dosimeter coupled to a patient-specific anthropomorphic phantom for proton therapy
|
Hillbrand, M.
|
|
2017
|
123 |
S1 |
p. S432-S433
2 p.
|
artikel
|
| 1119 |
PO-0653: A heart atlas for breast RT and the influence of delineation education on observer variability
|
Kirli, M.
|
|
2017
|
123 |
S1 |
p. S341-
1 p.
|
artikel
|
| 1120 |
PO-0853: A method for automatic selection of parameters in NTCP modelling
|
Christophides, D.
|
|
2017
|
123 |
S1 |
p. S463-S464
2 p.
|
artikel
|
| 1121 |
PO-0769: A microDiamond for determination of absorbed dose around high-dose-rate 192Ir brachytherapy sources
|
Kaveckyte, V.
|
|
2017
|
123 |
S1 |
p. S407-
1 p.
|
artikel
|
| 1122 |
PO-0629: A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
|
Niyazi, M.
|
|
2017
|
123 |
S1 |
p. S329-
1 p.
|
artikel
|
| 1123 |
PO-0954: A model to study long-term impact of radiation towards the colorectal area
|
Sjöberg, F.
|
|
2017
|
123 |
S1 |
p. S527-S528
2 p.
|
artikel
|
| 1124 |
PO-0857: Analysis of Intrafraction Motion in Image-Guided Stereotactic Radiosurgery of Spinal metastases
|
Svestad, J.G.
|
|
2017
|
123 |
S1 |
p. S466-
1 p.
|
artikel
|
| 1125 |
PO-0967: Analysis of tumour microenvironment using multi-parametric PET/MR imaging in HNSCC xenograft models
|
Boeke, S.
|
|
2017
|
123 |
S1 |
p. S534-
1 p.
|
artikel
|
| 1126 |
PO-0913: A national review of equipment, techniques and PTV margins used for SRS
|
Patel, R.
|
|
2017
|
123 |
S1 |
p. S505-S506
2 p.
|
artikel
|
| 1127 |
PO-0817: Anatomical robust optimization to deal with variation in nasal cavity filling during IMPT
|
Van de Water, S.
|
|
2017
|
123 |
S1 |
p. S437-S438
2 p.
|
artikel
|
| 1128 |
PO-0928: Androgen deprivation therapy influences PSA bounce rate after brachytherapy
|
Burchardt, W.
|
|
2017
|
123 |
S1 |
p. S514-
1 p.
|
artikel
|
| 1129 |
PO-1021: An electronically configurable checklist program for quality control of RT treatment planning
|
Grosser, K.H.
|
|
2017
|
123 |
S1 |
p. S563-
1 p.
|
artikel
|
| 1130 |
PO-0822: An evolutionary model improvement strategy for knowledge-based planning
|
Zhang, Y.
|
|
2017
|
123 |
S1 |
p. S441-S442
2 p.
|
artikel
|
| 1131 |
PO-0690: An initial result of carbon-ion radiotherapy for metastatic liver tumors.
|
Toyama, S.
|
|
2017
|
123 |
S1 |
p. S360-S361
2 p.
|
artikel
|
| 1132 |
PO-0641: A novel voxel based homogeneity index: clinical implications for WBRT
|
Thieme, A.H.
|
|
2017
|
123 |
S1 |
p. S335-S336
2 p.
|
artikel
|
| 1133 |
PO-0983: Antrodia cinnamomea Regulates DNA Repair and Enhances Radiosensitivity of Esophageal Cancer Cells
|
Liu, Y.M.
|
|
2017
|
123 |
S1 |
p. S543-
1 p.
|
artikel
|
| 1134 |
PO-0785: A pencil beam algorithm for protons including magnetic fields effects
|
Padilla, F.
|
|
2017
|
123 |
S1 |
p. S416-S417
2 p.
|
artikel
|
| 1135 |
PO-0604: A PET-based nomogram to predict survival in oropharyngeal cancers radiotherapy
|
Castelli, J.
|
|
2017
|
123 |
S1 |
p. S315-
1 p.
|
artikel
|
| 1136 |
PO-0715: A phase II study of chemoradiation with triweekly cycles of nedaplatin for uterine cervical cancer.
|
Okuma, K.
|
|
2017
|
123 |
S1 |
p. S375-
1 p.
|
artikel
|
| 1137 |
PO-0869: A population-based estimate of proton beam specific range uncertainties in the thorax
|
Szeto, Y.Z.
|
|
2017
|
123 |
S1 |
p. S473-S474
2 p.
|
artikel
|
| 1138 |
PO-0908: Application of Failure Mode and Effects Analysis to linac quality controls: advantages and limits
|
Bonfantini, F.
|
|
2017
|
123 |
S1 |
p. S502-S503
2 p.
|
artikel
|
| 1139 |
PO-0696: A predictive nomogram for decision support for patients with pancreatic neuroendocrine tumors
|
Jochems, A.
|
|
2017
|
123 |
S1 |
p. S364-
1 p.
|
artikel
|
| 1140 |
PO-0851: Artificial neural networks for toxicity prediction in RT: a method to validate their “intelligence”
|
Massari, E.
|
|
2017
|
123 |
S1 |
p. S461-S462
2 p.
|
artikel
|
| 1141 |
PO-0706: Assessing the impact of sentinel lymph-node and inguinal irradiation in patients with anal cancer
|
Gumina, C.
|
|
2017
|
123 |
S1 |
p. S370-
1 p.
|
artikel
|
| 1142 |
PO-0885: Assess Tumor Voxel Dose Response (SF2) Using Multiple FDG PET Images
|
Yan, D.
|
|
2017
|
123 |
S1 |
p. S485-S486
2 p.
|
artikel
|
| 1143 |
PO-0764: A study of Tandem systems incorporating three thermoluminescent dosimetry materials
|
Nelson, V.
|
|
2017
|
123 |
S1 |
p. S403-S404
2 p.
|
artikel
|
| 1144 |
PO-0897: Atlas-based auto-segmentation of heart structures in breast cancer patients
|
Kaderka, R.
|
|
2017
|
123 |
S1 |
p. S495-
1 p.
|
artikel
|
| 1145 |
PO-0834: Automated planning to reduce integral dose in robotic radiosurgery for benign tumors
|
Rossi, L.
|
|
2017
|
123 |
S1 |
p. S449-S450
2 p.
|
artikel
|
| 1146 |
PO-0898: Automated segmentation for breast cancer radiation therapy based on the ESTRO delineation guideline
|
Eldesoky, A.R.
|
|
2017
|
123 |
S1 |
p. S495-S496
2 p.
|
artikel
|
| 1147 |
PO-0892: Automatic quality assurance of rectal contours on image guidance scans
|
Romanchikova, M.
|
|
2017
|
123 |
S1 |
p. S491-
1 p.
|
artikel
|
| 1148 |
PO-0821: Automatic re-planning of VMAT plans in prostate and HN patients using constrained optimization
|
Künzel, L.
|
|
2017
|
123 |
S1 |
p. S440-S441
2 p.
|
artikel
|
| 1149 |
PO-1005: Automatic segmentation of cardiac sub-structures in the treatment of HL
|
Fiandra, C.
|
|
2017
|
123 |
S1 |
p. S554-
1 p.
|
artikel
|
| 1150 |
PO-0845: Automatic treatment planning of FFF VMAT for breast cancer: fast planning and fast treatment
|
Lorenzen, E.L.
|
|
2017
|
123 |
S1 |
p. S456-S457
2 p.
|
artikel
|
| 1151 |
PO-0884: Availability of MRI improves interobserver variation in CT-based pancreatic tumor delineation
|
Gurney-Champion, O.J.
|
|
2017
|
123 |
S1 |
p. S484-S485
2 p.
|
artikel
|
| 1152 |
PO-0801: Benchmarking Gate/Geant4 for oxygen ion beams against experimental data
|
Resch, A.
|
|
2017
|
123 |
S1 |
p. S427-
1 p.
|
artikel
|
| 1153 |
PO-0712: Benefit of semi-extended field radiotherapy in patients with locally advanced cervical cancer
|
Lee, J.
|
|
2017
|
123 |
S1 |
p. S373-S374
2 p.
|
artikel
|
| 1154 |
PO-0964: Biomarkers in wound drainage fluids affect response to radiations of head and neck cancer cells
|
Mangoni, M.
|
|
2017
|
123 |
S1 |
p. S532-S533
2 p.
|
artikel
|
| 1155 |
PO-0974: Biomarkers of radiosensitivity for patient stratification and personalized radiotherapy treatment
|
Palumbo, E.
|
|
2017
|
123 |
S1 |
p. S538-S539
2 p.
|
artikel
|
| 1156 |
PO-0752: Birth outcomes in female cancer patients received radiotherapy: a nationwide population-based study
|
Kao, W.H.
|
|
2017
|
123 |
S1 |
p. S396-S397
2 p.
|
artikel
|
| 1157 |
PO-0846: Bowel dose-volume relationship for patientreported acute intestinal toxicity from pelvic IMRT
|
Sini, C.
|
|
2017
|
123 |
S1 |
p. S457-S458
2 p.
|
artikel
|
| 1158 |
PO-0703: Bowel dysfunction resulting from different treatment strategies in patients with rectal cancer.
|
Vuong, T.
|
|
2017
|
123 |
S1 |
p. S368-
1 p.
|
artikel
|
| 1159 |
PO-0744: Brachytherapy and external beam radiation therapy after re-excision surgery in soft tissue sarcomas
|
Cortesi, A.
|
|
2017
|
123 |
S1 |
p. S391-S392
2 p.
|
artikel
|
| 1160 |
PO-0934: Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma
|
Chargari, C.
|
|
2017
|
123 |
S1 |
p. S517-
1 p.
|
artikel
|
| 1161 |
PO-0728: BRCA2 mutation predicts poor survival in prostate cancer: A compelling evidence from 8,988 patients
|
Cui, M.
|
|
2017
|
123 |
S1 |
p. S382-
1 p.
|
artikel
|
| 1162 |
PO-0972: Breast cancer cell survival using flattening filter-free beam compared to a standard flattened beam
|
Boccia, M.
|
|
2017
|
123 |
S1 |
p. S537-S538
2 p.
|
artikel
|
| 1163 |
PO-0657: Breast cancer subtypes and incidence/survival in patients with brain metastases
|
Tsai, Y.C.
|
|
2017
|
123 |
S1 |
p. S343-
1 p.
|
artikel
|
| 1164 |
PO-0615: Can diffusion-weighted MRI predict for xerostomia and QoL in head and neck patients receiving RT?
|
Nguyen, K.
|
|
2017
|
123 |
S1 |
p. S321-
1 p.
|
artikel
|
| 1165 |
PO-0635: Can psychological support during RT improve distress, mood or quality of life in CNS tumor patients?
|
Dinapoli, L.
|
|
2017
|
123 |
S1 |
p. S332-S333
2 p.
|
artikel
|
| 1166 |
PO-0911: Can the therapeutic benefits of microbeam radiation therapy be achieved using a clinical linac?
|
Suchowerska, N.
|
|
2017
|
123 |
S1 |
p. S504-S505
2 p.
|
artikel
|
| 1167 |
PO-0813: Cardiac Toxicity after Radiotherapy for Hodgkin Lymphoma: Impact of Breath Hold and Proton Therapy
|
Rechner, L.A.
|
|
2017
|
123 |
S1 |
p. S435-
1 p.
|
artikel
|
| 1168 |
PO-0860: Characterization of a novel liquid fiducial marker for organ motion monitoring in prostate SBRT
|
De Roover, R.
|
|
2017
|
123 |
S1 |
p. S467-S468
2 p.
|
artikel
|
| 1169 |
PO-0763: Characterizing the response of Gafchromic EBT3 film in a 1.5 T magnetic field
|
Roed, Y.
|
|
2017
|
123 |
S1 |
p. S403-
1 p.
|
artikel
|
| 1170 |
PO-0756: Characterizing tissue equivalent materials used for an end-to-end QA phantom for MR-guided RT
|
Steinmann, A.
|
|
2017
|
123 |
S1 |
p. S398-S399
2 p.
|
artikel
|
| 1171 |
PO-0984: Checkpoint HLA-G or its ligands ILT2/ILT4 changes radiosensitivity of renal carcinoma cell lines
|
Hennequin, C.
|
|
2017
|
123 |
S1 |
p. S543-S544
2 p.
|
artikel
|
| 1172 |
PO-0842: Choosing the best heart sparing technique for breast and internal mammary chain radiotherapy
|
Ranger, A.
|
|
2017
|
123 |
S1 |
p. S455-
1 p.
|
artikel
|
| 1173 |
PO-0991: Chromosomal radiosensitivity and genomic instability of Fanconi anaemia patients in South Africa
|
Francies, F.Z.
|
|
2017
|
123 |
S1 |
p. S547-
1 p.
|
artikel
|
| 1174 |
PO-0704: Circulating angiogenesis factors predicting poor chemoradiotherapy outcome in rectal cancer
|
Meltzer, S.
|
|
2017
|
123 |
S1 |
p. S368-S369
2 p.
|
artikel
|
| 1175 |
PO-0883: Clinical Implementation Model-Based CT to Replace 4DCT for Lung Cancer Treatment Planning
|
Low, D.
|
|
2017
|
123 |
S1 |
p. S484-
1 p.
|
artikel
|
| 1176 |
PO-0931: Clinical outcome and quality of life after MRIguided HDR boost for prostate cancer
|
Lakosi, F.
|
|
2017
|
123 |
S1 |
p. S516-
1 p.
|
artikel
|
| 1177 |
PO-0689: clinical target volume in biliary carcinoma: a systematic review of pathological studies
|
Marinelli, I.
|
|
2017
|
123 |
S1 |
p. S360-
1 p.
|
artikel
|
| 1178 |
PO-0975: Clinical utilization of the radiation-hypoxiainduced abscopal/bystander effect in lung cancer
|
Tubin, S.
|
|
2017
|
123 |
S1 |
p. S539-S540
2 p.
|
artikel
|
| 1179 |
PO-0803: CloudMC, a Cloud Computing application for fast Monte Carlo treatment verification
|
Miras, H.
|
|
2017
|
123 |
S1 |
p. S428-S429
2 p.
|
artikel
|
| 1180 |
PO-0990: Combining radiotherapy and notch inhibition in melanoma
|
Thippu Jayaprakash, K.
|
|
2017
|
123 |
S1 |
p. S546-S547
2 p.
|
artikel
|
| 1181 |
PO-0865: Commissioning and clinical implementation of intra-fractional 4D-CBCT imaging for lung SBRT
|
Sims, R.
|
|
2017
|
123 |
S1 |
p. S471-
1 p.
|
artikel
|
| 1182 |
PO-0805: Commissioning of the new Monte Carlo algorithm SciMoCa for a VersaHD LINAC
|
Lechner, W.
|
|
2017
|
123 |
S1 |
p. S429-S430
2 p.
|
artikel
|
| 1183 |
PO-0894: Comparing the spatial integrity of 7T and 3T MR images for image-guided radiotherapy of brain tumors
|
Peerlings, J.
|
|
2017
|
123 |
S1 |
p. S492-S493
2 p.
|
artikel
|
| 1184 |
PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC
|
Schmidt, S.
|
|
2017
|
123 |
S1 |
p. S323-S324
2 p.
|
artikel
|
| 1185 |
PO-1002: Comparison of Best Commercial Model and Atlas based segmentation with CT and MR in brain cancer
|
Woo, J.Y.
|
|
2017
|
123 |
S1 |
p. S552-S553
2 p.
|
artikel
|
| 1186 |
PO-0939: Comparison of brachytherapy sources of endometrial cancer: Electronic brachytherapy source and 192Ir
|
Lozares, S.
|
|
2017
|
123 |
S1 |
p. S519-S520
2 p.
|
artikel
|
| 1187 |
PO-0808: Comparison of multi-institutional QA for VMAT of Nasopharynx with simulated delivery errors
|
Thwaites, D.I.
|
|
2017
|
123 |
S1 |
p. S431-S432
2 p.
|
artikel
|
| 1188 |
PO-0795: Comparison of Service graph log and Dynamic linac log of Elekta Linacs for patient QA
|
Kowatsch, M.
|
|
2017
|
123 |
S1 |
p. S423-S424
2 p.
|
artikel
|
| 1189 |
PO-0998: Comparison of the accuracy of different pillow for radiation therapy of head and neck cancer
|
Lin, C.Y.
|
|
2017
|
123 |
S1 |
p. S550-
1 p.
|
artikel
|
| 1190 |
PO-0731: Comparison of two fractionation schemes in prostate cancer patients treated with robotic SBRT
|
Akyol, F.
|
|
2017
|
123 |
S1 |
p. S384-
1 p.
|
artikel
|
| 1191 |
PO-0794: Comprehensive quality assurance test for high precision teletherapy
|
Wegener, S.
|
|
2017
|
123 |
S1 |
p. S422-S423
2 p.
|
artikel
|
| 1192 |
PO-0710: Concurrent chemoradiotherapy in locally advanced cancer cervix: Systematic review and meta-analysis
|
Datta, N.R.
|
|
2017
|
123 |
S1 |
p. S372-
1 p.
|
artikel
|
| 1193 |
PO-0775: Contributions to detector response in arbitrary photon fields
|
Wegener, S.
|
|
2017
|
123 |
S1 |
p. S410-S411
2 p.
|
artikel
|
| 1194 |
PO-0999: Control of rectal volume with Kampo formula during prostate radiotherapy: A prospective study
|
Kobayashi, J.
|
|
2017
|
123 |
S1 |
p. S550-S551
2 p.
|
artikel
|
| 1195 |
PO-0628: Correlation between 18F-FDOPA uptake and tumor relapse in recurrent high-grade gliomas
|
Chabert, I.
|
|
2017
|
123 |
S1 |
p. S328-S329
2 p.
|
artikel
|
| 1196 |
PO-0862: Correlation of Liver and Pancreas Tumor motion with Normal Anatomical Stru ctures
|
Kaderka, R.
|
|
2017
|
123 |
S1 |
p. S469-
1 p.
|
artikel
|
| 1197 |
PO-0955: Co-treatment of MSC and vascular permeability inhibitor reduces radiation side effects on the colon
|
Monceau, V.
|
|
2017
|
123 |
S1 |
p. S528-
1 p.
|
artikel
|
| 1198 |
PO-0670: CPAP ventilation might allow better sparing of normal lung tissue during lung cancer radiotherapy
|
Di Perri, D.
|
|
2017
|
123 |
S1 |
p. S350-S351
2 p.
|
artikel
|
| 1199 |
PO-0930: CT to TRUS based Prostate HDR: what is the optimal dosimetric margin to use?
|
Lacroix, F.
|
|
2017
|
123 |
S1 |
p. S515-S516
2 p.
|
artikel
|
| 1200 |
PO-0720: CTV change during adaptive EBRT for cervix cancer: is mid-treatment plan adaptation required?
|
Vignarajah, D.D.
|
|
2017
|
123 |
S1 |
p. S377-S378
2 p.
|
artikel
|
| 1201 |
PO-0672: Delineation and eye-tracking: How to analyze treatment decisions according physician experience?
|
Legouté, F.
|
|
2017
|
123 |
S1 |
p. S351-S352
2 p.
|
artikel
|
| 1202 |
PO-0789: Demystifying failed VMAT PSQA measurements with ArcCHECK
|
Kinsella, P.
|
|
2017
|
123 |
S1 |
p. S419-
1 p.
|
artikel
|
| 1203 |
PO-0608: Depression, anxiety and claustrophobia in patients undergoing radiotherapy for head and neck cancer
|
Pelland, M.E.
|
|
2017
|
123 |
S1 |
p. S317-S318
2 p.
|
artikel
|
| 1204 |
PO-0791: Determination of water mean ionization potential for Geant4 simulations of therapeutical ion beams
|
Perales, A.
|
|
2017
|
123 |
S1 |
p. S420-S421
2 p.
|
artikel
|
| 1205 |
PO-1025: Development of a in-house KPI tool
|
Wallis, A.
|
|
2017
|
123 |
S1 |
p. S565-
1 p.
|
artikel
|
| 1206 |
PO-0904: Development of an MRI-protocol for radiotherapy treatment guidance in gastric cancer
|
Van Pelt, V.W.J.
|
|
2017
|
123 |
S1 |
p. S499-S500
2 p.
|
artikel
|
| 1207 |
PO-0758: Development of patient-specific phantoms for verification of SBRT planning using 3D printer
|
Hong, C.S.
|
|
2017
|
123 |
S1 |
p. S399-S400
2 p.
|
artikel
|
| 1208 |
PO-0870: DIBH produces a meaningful reduction in lung dose for some women with right-sided breast cancer
|
Conway, J.L.
|
|
2017
|
123 |
S1 |
p. S474-
1 p.
|
artikel
|
| 1209 |
PO-0879: Differences between planned and delivered maximum spinal cord dose in Head &Neck cancer patients
|
Noble, D.
|
|
2017
|
123 |
S1 |
p. S480-S481
2 p.
|
artikel
|
| 1210 |
PO-0979: Differential response of glioma cell lines to microbeam versus conventional radiotherapy
|
Smyth, L.
|
|
2017
|
123 |
S1 |
p. S541-S542
2 p.
|
artikel
|
| 1211 |
PO-0713: Diffusion-weighted MRI for predicting prognosis after radiotherapy in stage IIIB cervical cancer
|
Watanabe, Y.
|
|
2017
|
123 |
S1 |
p. S374-S375
2 p.
|
artikel
|
| 1212 |
PO-0973: Dimensionality reduction of clonogenic survival data to identify candidates for radiosensitization
|
Brix, N.
|
|
2017
|
123 |
S1 |
p. S538-
1 p.
|
artikel
|
| 1213 |
PO-0701: Discrepancies between pathological data on nodal spread and the CTVs in RT for biliary tract cancer
|
Socha, J.
|
|
2017
|
123 |
S1 |
p. S367-
1 p.
|
artikel
|
| 1214 |
PO-0709: Disease courses in women with residual tumor after concurrent chemoradiotherapy for cervical cancer
|
Kim, Y.S.
|
|
2017
|
123 |
S1 |
p. S371-S372
2 p.
|
artikel
|
| 1215 |
PO-0981: Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma
|
Zhang, H.
|
|
2017
|
123 |
S1 |
p. S542-S543
2 p.
|
artikel
|
| 1216 |
PO-0940: 3D mapping for precise definition of GTV, CTV and their correlation in cervix cancer BT (EMBRACE)
|
Banerjee, S.
|
|
2017
|
123 |
S1 |
p. S520-S521
2 p.
|
artikel
|
| 1217 |
PO-0881: 4DMRI for RT planning; novel precise amplitude binning in the presence of irregular breathing
|
Bones, I.
|
|
2017
|
123 |
S1 |
p. S482-S483
2 p.
|
artikel
|
| 1218 |
PO-0961: DNA damage and repair influence tumor sensitivity to diffusing alpha emitters radiation therapy
|
Keisari, Y.
|
|
2017
|
123 |
S1 |
p. S531-
1 p.
|
artikel
|
| 1219 |
PO-0923: Does catheter entry-exit dosimetry correlate with grade of skin marks after breast brachytherapy?
|
Wadasadawala, T.
|
|
2017
|
123 |
S1 |
p. S511-S512
2 p.
|
artikel
|
| 1220 |
PO-0921: Dose considerations of IGRT using MV projection and MV CBCT on a prototype linear accelerator
|
Balter, P.
|
|
2017
|
123 |
S1 |
p. S510-S511
2 p.
|
artikel
|
| 1221 |
PO-0936: Dose effects of draining rectal gas in imageguided brachytherapy for gynecological cancer
|
Takase, H.
|
|
2017
|
123 |
S1 |
p. S518-
1 p.
|
artikel
|
| 1222 |
PO-0726: Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
|
Chicas-Sett, R.
|
|
2017
|
123 |
S1 |
p. S380-S381
2 p.
|
artikel
|
| 1223 |
PO-1017: Dose guided adaptive radiotherapy based on cumulated dose in OAR for prostate cancer
|
Nassef, M.
|
|
2017
|
123 |
S1 |
p. S561-S562
2 p.
|
artikel
|
| 1224 |
PO-0837: Dosimetric advantages afforded by Dynamic WaveArc therapy accelerated partial breast irradiation
|
Ono, Y.
|
|
2017
|
123 |
S1 |
p. S451-S452
2 p.
|
artikel
|
| 1225 |
PO-1015: Dosimetric comparison of the breath-hold based and conventional radiation therapy of lung cancer
|
Choi, A.H.
|
|
2017
|
123 |
S1 |
p. S560-
1 p.
|
artikel
|
| 1226 |
PO-0875: Dosimetric effects of anatomical changes in proton therapy of head and neck (H&N) cancer
|
Miori, G.
|
|
2017
|
123 |
S1 |
p. S477-S478
2 p.
|
artikel
|
| 1227 |
PO-0806: Dosimetric end-to-end test procedures using alanine dosimetry in scanned proton beam therapy
|
Carlino, A.
|
|
2017
|
123 |
S1 |
p. S430-
1 p.
|
artikel
|
| 1228 |
PO-0844: Dosimetric Evaluation of MLC and Fixed Cone for Patients in the Prone Position with CyberKnife
|
Ahn, S.K.
|
|
2017
|
123 |
S1 |
p. S456-
1 p.
|
artikel
|
| 1229 |
PO-0812: Dosimetric impact of using Acuros algorithm for stereotactic lung and spine treatments
|
Vieillevigne, L.
|
|
2017
|
123 |
S1 |
p. S434-S435
2 p.
|
artikel
|
| 1230 |
PO-0944: Dosimetric influence produced by the presence of an air gap between the skin and the freiburg flap
|
Fernandez Montes, M.
|
|
2017
|
123 |
S1 |
p. S523-
1 p.
|
artikel
|
| 1231 |
PO-0761: Dosimetry with Farmer ionization chambers in magnetic fields: Influence of the sensitive volume
|
Spindeldreier, C.K.
|
|
2017
|
123 |
S1 |
p. S401-S402
2 p.
|
artikel
|
| 1232 |
PO-0986: Downregulation of the oncoprotein SET enhances RT-induced apoptosis in hepatocellular carcinoma
|
Huang, C.Y.
|
|
2017
|
123 |
S1 |
p. S544-S545
2 p.
|
artikel
|
| 1233 |
PO-0886: Early changes of FDG-PET markers predict the outcome after chemo-radiotherapy for pancreatic cancer
|
Broggi, S.
|
|
2017
|
123 |
S1 |
p. S486-S487
2 p.
|
artikel
|
| 1234 |
PO-0749: Early impact of pulmonary SBRT on Quality of Life: Benefit for patients with low initial QoL/GHS
|
Adebahr, S.
|
|
2017
|
123 |
S1 |
p. S395-
1 p.
|
artikel
|
| 1235 |
PO-0663: Early toxicity of 150 patients treated with hypofractionated breast SIB-RT using advanced Techniques
|
Lakosi, F.
|
|
2017
|
123 |
S1 |
p. S346-S347
2 p.
|
artikel
|
| 1236 |
PO-1024: Effectiveness of couch coordinate constraints to reduce error rates in radiation therapy delivery
|
Nairz, O.
|
|
2017
|
123 |
S1 |
p. S564-S565
2 p.
|
artikel
|
| 1237 |
PO-0613: Effect of geometric GTV-CTV margins in national contouring guidelines
|
Hansen, C.R.
|
|
2017
|
123 |
S1 |
p. S319-S320
2 p.
|
artikel
|
| 1238 |
PO-0610: Effects of an oral health promotion program in head and neck cancer patients receiving radiotherapy
|
Kim, E.
|
|
2017
|
123 |
S1 |
p. S318-
1 p.
|
artikel
|
| 1239 |
PO-0748: Efficacy of radiotherapy for painful bone metastases in elderly patients
|
Cacicedo, J.
|
|
2017
|
123 |
S1 |
p. S394-S395
2 p.
|
artikel
|
| 1240 |
PO-0737: elective pelvic radiotherapy in clinically node-negative prostate cancer: a long-term analysis
|
Catucci, F.
|
|
2017
|
123 |
S1 |
p. S387-S388
2 p.
|
artikel
|
| 1241 |
PO-0768: Electron Paramagnetic Resonance signal from a new solid polymer material aimed for 3D dosimetry
|
Bernal-Zamorano, M.R.
|
|
2017
|
123 |
S1 |
p. S406-S407
2 p.
|
artikel
|
| 1242 |
PO-0786: Energy dependence investigation for detectors used in out-of-filed dosimetry
|
Shields, L.
|
|
2017
|
123 |
S1 |
p. S417-
1 p.
|
artikel
|
| 1243 |
PO-0946: Entropic model for real-time dose calculation: I-125 prostate brachytherapy application
|
Birindelli, G.
|
|
2017
|
123 |
S1 |
p. S524-
1 p.
|
artikel
|
| 1244 |
PO-0951: Episcleral Brachytherapy for Uveal Melanoma
|
Ponte, A.
|
|
2017
|
123 |
S1 |
p. S526-
1 p.
|
artikel
|
| 1245 |
PO-0971: Estimating second malignancy risk in IMRT and VMAT in radiotherapy for carcinoma of left breast
|
Selvaraj, J.
|
|
2017
|
123 |
S1 |
p. S536-S537
2 p.
|
artikel
|
| 1246 |
PO-0995: Estimation of radiobiology parameters of infiltrative low-grade gliomas WHO Grade II
|
Milyukov, S.
|
|
2017
|
123 |
S1 |
p. S549-
1 p.
|
artikel
|
| 1247 |
PO-0675: Evaluating commercial delineation software in routine clinical practice: analyzing time and quality.
|
Lustberg, T.
|
|
2017
|
123 |
S1 |
p. S353-
1 p.
|
artikel
|
| 1248 |
PO-1006: Evaluation of an auto-segmentation software for definition of organs at risk in radiotherapy
|
Herraiz Lablanca, M.D.
|
|
2017
|
123 |
S1 |
p. S554-
1 p.
|
artikel
|
| 1249 |
PO-0943: Evaluation of a recent in vivo dosimetry methodology for HDR prostate BT using MOSFET detectors
|
Fabregat Borrás, R.
|
|
2017
|
123 |
S1 |
p. S522-S523
2 p.
|
artikel
|
| 1250 |
PO-0949: Evaluation of role of Interstitial Brachytherapy in Soft Tissue Sarcoma: Single institute experience
|
Pareek, V.
|
|
2017
|
123 |
S1 |
p. S525-S526
2 p.
|
artikel
|
| 1251 |
PO-1009: Evaluation of setup margins using cone-beam CT for prostate and pelvic nodes irradiation
|
Van Nunen, A.
|
|
2017
|
123 |
S1 |
p. S556-
1 p.
|
artikel
|
| 1252 |
PO-1001: Evaluation of target volume delineation of the regional lymph nodes in breast cancer patients
|
Mast, M.
|
|
2017
|
123 |
S1 |
p. S552-
1 p.
|
artikel
|
| 1253 |
PO-0826: Evaluation of the new InCise MLC for Cyberknife stereotactic radiotherapy
|
Limoges, C.
|
|
2017
|
123 |
S1 |
p. S444-
1 p.
|
artikel
|
| 1254 |
PO-0868: Evaluation of Watchdog response to anatomical changes during head and neck IMRT treatment
|
Fuangrod, T.
|
|
2017
|
123 |
S1 |
p. S473-
1 p.
|
artikel
|
| 1255 |
PO-0887: Experimental validation of a 3D model to simulate FMISO spatial retention in HNSCC tumor xenografts
|
Wack, L.J.M.
|
|
2017
|
123 |
S1 |
p. S487-S488
2 p.
|
artikel
|
| 1256 |
PO-0802: Experimental validation of single detector proton radiography with scanning beams
|
Chirvase, C.
|
|
2017
|
123 |
S1 |
p. S427-S428
2 p.
|
artikel
|
| 1257 |
PO-0815: External neutron spectra measurements for a single room compact proton system
|
Howell, R.
|
|
2017
|
123 |
S1 |
p. S436-S437
2 p.
|
artikel
|
| 1258 |
PO-0852: External validation of a TCP model predicting PSA relapse after post-prostatectomy Radiotherapy
|
Broggi, S.
|
|
2017
|
123 |
S1 |
p. S462-S463
2 p.
|
artikel
|
| 1259 |
PO-0605: Factors associated with late dysphagia and xerostomia in (chemo)radiation for head and neck cancer
|
Duprez, F.
|
|
2017
|
123 |
S1 |
p. S315-S316
2 p.
|
artikel
|
| 1260 |
PO-0647: Factors associated with pulmonary toxicity after conditioning with total body irradiation
|
Byun, H.K.
|
|
2017
|
123 |
S1 |
p. S338-
1 p.
|
artikel
|
| 1261 |
PO-0654: Failure Patterns of Luminal B Breast Cancer Following Postoperative Adjuvant Radiation Therapy
|
Choi, N.
|
|
2017
|
123 |
S1 |
p. S341-S342
2 p.
|
artikel
|
| 1262 |
PO-0750: Failure to publish the results of clinical trials in oncology is skewing our medical practice
|
Gallego, P.
|
|
2017
|
123 |
S1 |
p. S395-S396
2 p.
|
artikel
|
| 1263 |
PO-0799: Fast protocol for radiochromic film dosimetry using a cloud computing web application
|
Calvo Ortega, J.F.
|
|
2017
|
123 |
S1 |
p. S426-
1 p.
|
artikel
|
| 1264 |
PO-0718: 18-FDG PET/CT parameters to predict survival and recurrence in cervical cancer
|
Scher, N.
|
|
2017
|
123 |
S1 |
p. S376-S377
2 p.
|
artikel
|
| 1265 |
PO-0916: Feasibility and potential for treating locally advanced non-small cell lung cancer with a MR-linac
|
Menten, M.J.
|
|
2017
|
123 |
S1 |
p. S507-S508
2 p.
|
artikel
|
| 1266 |
PO-0841: Feasibility of dose decrease in a rectal subregion predictive of bleeding in prostate radiotherapy
|
Lafond, C.
|
|
2017
|
123 |
S1 |
p. S454-S455
2 p.
|
artikel
|
| 1267 |
PO-1008: Feasibility of stereotactic ablative radiotherapy for locally-advanced non-small cell lung cancer
|
Woodford, K.
|
|
2017
|
123 |
S1 |
p. S555-S556
2 p.
|
artikel
|
| 1268 |
PO-0639: Feasibility of tract based dosimetric analysis in brain tumor patients
|
Conson, M.
|
|
2017
|
123 |
S1 |
p. S334-S335
2 p.
|
artikel
|
| 1269 |
PO-0780: Feasibility study of beam monitoring system using AFCRS for proton pencil beam
|
Son, J.M.
|
|
2017
|
123 |
S1 |
p. S413-S414
2 p.
|
artikel
|
| 1270 |
PO-0638: FET PET prior to primary RT of glioblastoma patients - a recurrence pattern analysis
|
Fleischmann, D.F.
|
|
2017
|
123 |
S1 |
p. S334-
1 p.
|
artikel
|
| 1271 |
PO-0609: 18F-FDG-PET in Guiding Dose-painting with IMRT in Oropharyngeal Tumours (FiGaRO) - Early Results
|
Michaelidou, A.
|
|
2017
|
123 |
S1 |
p. S318-
1 p.
|
artikel
|
| 1272 |
PO-0788: First assessment of Delivery Analysis tool for pre-treatment verification on the new Radixact system
|
Girardi, A.
|
|
2017
|
123 |
S1 |
p. S418-
1 p.
|
artikel
|
| 1273 |
PO-0668: Five-fraction SBRT for central NSCLC in-field recurrences following high-dose conventional radiation
|
Repka, M.C.
|
|
2017
|
123 |
S1 |
p. S349-S350
2 p.
|
artikel
|
| 1274 |
PO-0651: Five year outcome and soft tissue toxicity of breast cancer hypofractionated adjuvant radiotherapy
|
Zerbetto, F.
|
|
2017
|
123 |
S1 |
p. S340-
1 p.
|
artikel
|
| 1275 |
PO-0889: FLT PET kinetic analysis biomarkers of resistance to radiotherapy for nasal tumours in canines
|
Simoncic, U.
|
|
2017
|
123 |
S1 |
p. S488-S489
2 p.
|
artikel
|
| 1276 |
PO-0988: Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis
|
Lallemand, F.
|
|
2017
|
123 |
S1 |
p. S545-
1 p.
|
artikel
|
| 1277 |
PO-0820: Full automation of radiation therapy treatment planning
|
Court, L.
|
|
2017
|
123 |
S1 |
p. S439-S440
2 p.
|
artikel
|
| 1278 |
PO-0617: Functional Brain Abnormalities in NPC Patients After Radiotherapy
|
Ren, W.
|
|
2017
|
123 |
S1 |
p. S322-S323
2 p.
|
artikel
|
| 1279 |
PO-0982: Fused Toes Homolog (FTS) is a potential target for Notch-mediated radioresistance in cervical cancer
|
Park, W.Y.
|
|
2017
|
123 |
S1 |
p. S543-
1 p.
|
artikel
|
| 1280 |
PO-0624: Gammaknife Radiosurgery in patients receiving anticancer immunotherapy: efficacy and safety
|
Greto, D.
|
|
2017
|
123 |
S1 |
p. S326-S327
2 p.
|
artikel
|
| 1281 |
PO-0987: Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells
|
Waissi, W.
|
|
2017
|
123 |
S1 |
p. S545-
1 p.
|
artikel
|
| 1282 |
PO-0861: Geometric validation of a 4D-MRI guided correction strategy on the MR-Linac
|
Van de Lindt, T.
|
|
2017
|
123 |
S1 |
p. S468-S469
2 p.
|
artikel
|
| 1283 |
PO-0666: 30 Gy single-dose SBRT to lung lesions: outcome in a large series of patients
|
Nicosia, L.
|
|
2017
|
123 |
S1 |
p. S348-S349
2 p.
|
artikel
|
| 1284 |
PO-0924: HDR boost in CT3 breast carcinoma with neoadjuvant chemotherapy and conserving therapy
|
Romero, F.
|
|
2017
|
123 |
S1 |
p. S512-
1 p.
|
artikel
|
| 1285 |
PO-0735: HDR-brachytherapy or SBRT for extreme hypofractionation in prostate cancer - long-term results
|
Aluwini, S.
|
|
2017
|
123 |
S1 |
p. S386-S387
2 p.
|
artikel
|
| 1286 |
PO-0937: HDR image-guided interstitial brachytherapy for postoperative local recurrent uterine cancer
|
Yoshida, K.
|
|
2017
|
123 |
S1 |
p. S518-S519
2 p.
|
artikel
|
| 1287 |
PO-0673: Healing of the bronchial anastomosis and time between neoadjuvant radiochemotherapy and surgery.
|
Koryllos, A.
|
|
2017
|
123 |
S1 |
p. S352-
1 p.
|
artikel
|
| 1288 |
PO-0678: Health-related quality of life reporting in lung cancer trials: A methodological appraisal.
|
Van der Weijst, L.
|
|
2017
|
123 |
S1 |
p. S354-S355
2 p.
|
artikel
|
| 1289 |
PO-0914: Helium Beam Radiography System based on pixelized semiconductor detectors
|
Gehrke, T.
|
|
2017
|
123 |
S1 |
p. S506-
1 p.
|
artikel
|
| 1290 |
PO-0637: HFSRT to the resection bed for intracranial metastases: a large retrospective study of 181 patients
|
Keller, A.
|
|
2017
|
123 |
S1 |
p. S333-S334
2 p.
|
artikel
|
| 1291 |
PO-0823: Hierarchical constrained optimization for automated SBRT paraspinal IMRT planning
|
Zarepisheh, M.
|
|
2017
|
123 |
S1 |
p. S442-
1 p.
|
artikel
|
| 1292 |
PO-0950: High-dose-rate brachytherapy treatment in T1-T2 stage non-melanoma skin cancer patients
|
González Ruiz, M.A.
|
|
2017
|
123 |
S1 |
p. S526-
1 p.
|
artikel
|
| 1293 |
PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
|
Linge, A.
|
|
2017
|
123 |
S1 |
p. S322-
1 p.
|
artikel
|
| 1294 |
PO-0659: Hypofractionated-accelerated concomitant boost in moderate-high risk breast cancer:phase I-II study
|
Boccardi, M.
|
|
2017
|
123 |
S1 |
p. S344-
1 p.
|
artikel
|
| 1295 |
PO-0840: Hypofractionated intensity modulated radiotherapy in patients with immediate breast reconstruction
|
Rojas, D.P.
|
|
2017
|
123 |
S1 |
p. S453-S454
2 p.
|
artikel
|
| 1296 |
PO-0798: Identification of areas of high-risk skin toxicity in SBRT and IMRT treatments
|
Carrasco de Fez, P.
|
|
2017
|
123 |
S1 |
p. S425-S426
2 p.
|
artikel
|
| 1297 |
PO-0902: Identifying the dominant prostate cancer focal lesion using 3D image texture analysis
|
Montgomery, D.
|
|
2017
|
123 |
S1 |
p. S498-S499
2 p.
|
artikel
|
| 1298 |
PO-0947: Image-guided brachytherapy with 106Ru eye plaques for uveal melanomas using post implantation MRI
|
Heilemann, G.
|
|
2017
|
123 |
S1 |
p. S524-S525
2 p.
|
artikel
|
| 1299 |
PO-0965: Imaging of the hypoxia related marker Carbonic Anhydrase IX in human head and neck cancer xenografts
|
Huizing, F.J.
|
|
2017
|
123 |
S1 |
p. S533-
1 p.
|
artikel
|
| 1300 |
PO-1000: Immobilisation systems for brain treatment: are individual head supports needed for stable fixation?
|
Meessen, S.
|
|
2017
|
123 |
S1 |
p. S551-S552
2 p.
|
artikel
|
| 1301 |
PO-0658: impact of breast radiation therapy on complications after alloplastic breast reconstruction
|
Chaves, C.D.L.G.
|
|
2017
|
123 |
S1 |
p. S343-S344
2 p.
|
artikel
|
| 1302 |
PO-1016: Impact of CBCT based IGRT strategies on margins in IMRT of gynecological tumors after hysterectomy
|
Buijs, M.
|
|
2017
|
123 |
S1 |
p. S560-S561
2 p.
|
artikel
|
| 1303 |
PO-0859: Impact of 4DCBCT reconstruction algorithm and surrogate on motion representation
|
Steiner, E.
|
|
2017
|
123 |
S1 |
p. S467-
1 p.
|
artikel
|
| 1304 |
PO-0836: Impact of Deep Inspiration Breath Hold on Left Anterior Coronary dose in Left Breast irradiation
|
Azoury, F.
|
|
2017
|
123 |
S1 |
p. S450-S451
2 p.
|
artikel
|
| 1305 |
PO-0636: Impact of DWI-MRI for gross tumor volume definition in patients with recurrent glioblastoma
|
Oehlke, O.
|
|
2017
|
123 |
S1 |
p. S333-
1 p.
|
artikel
|
| 1306 |
PO-0623: Impact of Interim Events during the Surgery-to-Radiotherapy Interval in Newly Diagnosed Glioblastoma
|
Wee, C.W.
|
|
2017
|
123 |
S1 |
p. S326-
1 p.
|
artikel
|
| 1307 |
PO-0683: Impact of the radiation dose on hepatic perfusion evaluated using mebrofenin liver scintigraphy
|
De Bari, B.
|
|
2017
|
123 |
S1 |
p. S357-
1 p.
|
artikel
|
| 1308 |
PO-1022: Implementation of a paperless workflow in radiotherapy; Reducing transcription
|
Shoffren, O.
|
|
2017
|
123 |
S1 |
p. S563-S564
2 p.
|
artikel
|
| 1309 |
PO-0755: Implementation of structural patient reported outcome registration in clinical practice
|
Nijsten - van Riesen, I.
|
|
2017
|
123 |
S1 |
p. S398-
1 p.
|
artikel
|
| 1310 |
PO-0777: Importance of dosimetry formalism for cells irradiation on a SARRP and consequences for RBE
|
Dos Santos, M.
|
|
2017
|
123 |
S1 |
p. S411-S412
2 p.
|
artikel
|
| 1311 |
PO-1018: Improvement of radiation-induced late toxicity after hyperbaric oxygen treatment
|
Roncero, R.
|
|
2017
|
123 |
S1 |
p. S562-
1 p.
|
artikel
|
| 1312 |
PO-0893: Improving CBCT image quality for daily image guidance of patients with head/neck and prostate cancer
|
Chetty, I.
|
|
2017
|
123 |
S1 |
p. S491-S492
2 p.
|
artikel
|
| 1313 |
PO-0818: Improving plan quality and efficiency by automated rectum VMAT treatment planning
|
Wortel, G.
|
|
2017
|
123 |
S1 |
p. S438-
1 p.
|
artikel
|
| 1314 |
PO-0997: Improving shoulder positioning in a 5-points mask
|
Mesch, L.
|
|
2017
|
123 |
S1 |
p. S549-S550
2 p.
|
artikel
|
| 1315 |
PO-0824: IMRT dose painting for prostate cancer using PSMA-PET/CT: a planning study based on histology
|
Koubar, K.
|
|
2017
|
123 |
S1 |
p. S442-S443
2 p.
|
artikel
|
| 1316 |
PO-0642: Influence of Introduction of VMAT and FET-PET on Treatment Outcomes for Glioblastoma Patients
|
Munck af Rosenschöld, P.
|
|
2017
|
123 |
S1 |
p. S336-
1 p.
|
artikel
|
| 1317 |
PO-0671: Influence of “radioresistant” histologies on SBRT outcome for lung metastases
|
Franceschini, D.
|
|
2017
|
123 |
S1 |
p. S351-
1 p.
|
artikel
|
| 1318 |
PO-0993: Influence of radiotherapy on differentiation, maturation and functionality of dendritic cells
|
König, L.
|
|
2017
|
123 |
S1 |
p. S548-
1 p.
|
artikel
|
| 1319 |
PO-0952: Integral heart dose and lymphocytopaenia in lung cancer patients treated with radical radiotherapy
|
Joseph, N.
|
|
2017
|
123 |
S1 |
p. S527-
1 p.
|
artikel
|
| 1320 |
PO-0994: Integrin antagonistic drugs reveal different effectiveness in 2D monolayer vs. 3D spheroid culture
|
Kopatz, V.
|
|
2017
|
123 |
S1 |
p. S548-S549
2 p.
|
artikel
|
| 1321 |
PO-0873: Inter- and intra-fraction motion of the tumor bed and organs at risk during IGRT for Wilms' tumor
|
Guerreiro, F.
|
|
2017
|
123 |
S1 |
p. S476-
1 p.
|
artikel
|
| 1322 |
PO-0746: Inter-observer variation in GTV delineation of bone metastases: a multicenter study
|
Gerlich, A.S.
|
|
2017
|
123 |
S1 |
p. S392-S393
2 p.
|
artikel
|
| 1323 |
PO-0926: Interstitial HDR prostate brachytherapy: comparison of pre- and post-implant dose distribution
|
Novikov, S.
|
|
2017
|
123 |
S1 |
p. S513-
1 p.
|
artikel
|
| 1324 |
PO-0745: Intrafractional movement of patients with spinal cord compression receiving radiation therapy
|
Ravnkilde, E.
|
|
2017
|
123 |
S1 |
p. S392-
1 p.
|
artikel
|
| 1325 |
PO-0858: Intra-fraction motion quantification of head-and-neck tumors using dynamic MRI
|
Bruijnen, T.
|
|
2017
|
123 |
S1 |
p. S466-S467
2 p.
|
artikel
|
| 1326 |
PO-0661: Intraoperative partial breast re-irradiation: a multicenter study of the AIRO IORT Working Group
|
Leonardi, M.C.
|
|
2017
|
123 |
S1 |
p. S345-
1 p.
|
artikel
|
| 1327 |
PO-0774: Investigation of dose-rate dependence at an extensive range for PRESAGE radiochromic dosimeter
|
Pappas, E.P.
|
|
2017
|
123 |
S1 |
p. S410-
1 p.
|
artikel
|
| 1328 |
PO-0760: Investigation of PRESAGE formulation on signal quenching in a proton beam
|
Carroll, M.
|
|
2017
|
123 |
S1 |
p. S401-
1 p.
|
artikel
|
| 1329 |
PO-1010: Investigation of reproducibility of bolus position based on kV CBCT imaging
|
Dabrowska, E.
|
|
2017
|
123 |
S1 |
p. S556-S557
2 p.
|
artikel
|
| 1330 |
PO-0790: In-vivo dosimetry for kV radiotherapy: clinical use of micro-silica bead TLD & Gafchromic EBT3 film
|
Palmer, A.L.
|
|
2017
|
123 |
S1 |
p. S419-S420
2 p.
|
artikel
|
| 1331 |
PO-0741: Ipilimumab and stereotactic radiosurgery with cyberknife in melanoma brain metastases
|
Borzillo, V.
|
|
2017
|
123 |
S1 |
p. S389-S390
2 p.
|
artikel
|
| 1332 |
PO-0634: Irradiation of Subventricular Zone in Glioblastoma: Its Impact on Tumor Progression and Survival
|
Sert, F.
|
|
2017
|
123 |
S1 |
p. S332-
1 p.
|
artikel
|
| 1333 |
PO-0648: Is age >60 unfavorable prognostic factor in early stage upper aerodigestive tract NK/T-cell lymphoma?
|
Chen, B.
|
|
2017
|
123 |
S1 |
p. S338-S339
2 p.
|
artikel
|
| 1334 |
PO-0754: ISIORT pooled analysis 2016: characteristics of intraoperative radiotherapy in 11,025 patients
|
Krengli, M.
|
|
2017
|
123 |
S1 |
p. S397-S398
2 p.
|
artikel
|
| 1335 |
PO-1011: Is it safe to omit a setup correction validation scan for central lung lesions treated with SBRT?
|
Rossi, M.M.G.
|
|
2017
|
123 |
S1 |
p. S557-S558
2 p.
|
artikel
|
| 1336 |
PO-0910: Is Linac-Based Total Body Irradiation (TBI) on the coach by VMAT Feasable?
|
Tas, B.
|
|
2017
|
123 |
S1 |
p. S504-
1 p.
|
artikel
|
| 1337 |
PO-0901: Is MRI in immobilization mask necessary for brain metastasis patients?
|
Van Lier, A.
|
|
2017
|
123 |
S1 |
p. S497-S498
2 p.
|
artikel
|
| 1338 |
PO-0854: Is radiation-induced trismus a time dependent masticatory structure story?
|
Thor, M.
|
|
2017
|
123 |
S1 |
p. S464-
1 p.
|
artikel
|
| 1339 |
PO-0699: Is stereotactic radiotherapy following radiochemotherapy useful in local advanced pancreatic cancer?
|
Mattiucci, G.
|
|
2017
|
123 |
S1 |
p. S366-
1 p.
|
artikel
|
| 1340 |
PO-0922: Late toxicity and cosmetic outcome following APBI using interstitial multicatheter HDR brachytherapy
|
Soror, T.
|
|
2017
|
123 |
S1 |
p. S511-
1 p.
|
artikel
|
| 1341 |
PO-1013: Library of plans and CTV-PTV margins for VMAT irradiation of cervical cancer
|
Kager, P.M.
|
|
2017
|
123 |
S1 |
p. S559-
1 p.
|
artikel
|
| 1342 |
PO-0649: Locoregional Treatment of the Primary Tumor Shows Survival Benefit in De Novo Stage IV Breast Cancer
|
Choi, S.H.
|
|
2017
|
123 |
S1 |
p. S339-
1 p.
|
artikel
|
| 1343 |
PO-0800: Log file based performance characterization of a PBS dose delivery system with dose re-computation
|
Böhlen, T.T.
|
|
2017
|
123 |
S1 |
p. S426-S427
2 p.
|
artikel
|
| 1344 |
PO-0736: Long term outcomes of IG-IMRT dose-escalation to pelvis and prostate for advanced prostate cancer
|
Lieng, H.
|
|
2017
|
123 |
S1 |
p. S387-
1 p.
|
artikel
|
| 1345 |
PO-0611: Long-term prognostic impacts of pretreatment plasma EBV DNA status in nasopharyngeal carcinoma
|
Lin, J.C.
|
|
2017
|
123 |
S1 |
p. S318-S319
2 p.
|
artikel
|
| 1346 |
PO-0992: Low-dose whole lung irradiation plus Re-188-liposome eliminates lung metastasis of esophageal cancer
|
Chen, Y.J.
|
|
2017
|
123 |
S1 |
p. S547-S548
2 p.
|
artikel
|
| 1347 |
PO-0816: LRPM for fast automated high quality treatment planning - towards a novel workflow for clinicians
|
Van Haveren, R.
|
|
2017
|
123 |
S1 |
p. S437-
1 p.
|
artikel
|
| 1348 |
PO-1004: Machine learning methods for automated OAR segmentation
|
Tegzes, P.
|
|
2017
|
123 |
S1 |
p. S553-S554
2 p.
|
artikel
|
| 1349 |
PO-0707: Magnetic Resonance Imaging Texture Analysis Parameters for predicting risk of Anal Cancer recurrence
|
Owczarczyk, K.
|
|
2017
|
123 |
S1 |
p. S370-S371
2 p.
|
artikel
|
| 1350 |
PO-0867: Magnitude and robustness of motion mitigation in stereotactic body radiation therapy of the liver
|
Heinz, C.
|
|
2017
|
123 |
S1 |
p. S472-S473
2 p.
|
artikel
|
| 1351 |
PO-0606: Mandible osteoradionecrosis in oropharynx carcinoma treated with IMRT: Smoking and tumor size matter
|
Caparrotti, F.
|
|
2017
|
123 |
S1 |
p. S316-
1 p.
|
artikel
|
| 1352 |
PO-0976: Mechanisms of normal tissue toxicity from SAHA, an HDAC inhibitor and radiosensitizer
|
Barua, I.S.
|
|
2017
|
123 |
S1 |
p. S540-
1 p.
|
artikel
|
| 1353 |
PO-0622: Medulloblastoma in adults: a retrospective single institution analysis
|
Hadi, I.
|
|
2017
|
123 |
S1 |
p. S325-S326
2 p.
|
artikel
|
| 1354 |
PO-0980: MEK/ERK pathway sustains radioresistance of embryonal rhabdomyosarcoma stem-like cell population
|
Marampon, F.
|
|
2017
|
123 |
S1 |
p. S542-
1 p.
|
artikel
|
| 1355 |
PO-0603: Metachronous Second Primary Head and Neck Squamous Cell Carcinoma
|
Wu, S.Y.
|
|
2017
|
123 |
S1 |
p. S315-
1 p.
|
artikel
|
| 1356 |
PO-1019: Mobile Oncology: Survey with Healthcare Professionals about Telemedicine, mHealth and mobile Apps
|
Kessel, K.
|
|
2017
|
123 |
S1 |
p. S562-S563
2 p.
|
artikel
|
| 1357 |
PO-0935: Modeling to compensate for intra-fractional bladder dose variations in gynecological brachytherapy
|
Siavashpour, Z.
|
|
2017
|
123 |
S1 |
p. S517-S518
2 p.
|
artikel
|
| 1358 |
PO-0669: Models of pulmonary function changes after thoracic radiotherapy
|
Niezink, A.G.H.
|
|
2017
|
123 |
S1 |
p. S350-
1 p.
|
artikel
|
| 1359 |
PO-0724: Moderate hypofractionated radiotherapy in prostate cancer: a meta-analysis from randomized trials
|
Yin, Z.
|
|
2017
|
123 |
S1 |
p. S379-S380
2 p.
|
artikel
|
| 1360 |
PO-0631: Molecular subtypes of glioblastoma: immunohistochemical approach and clinical correlations
|
Triggiani, L.
|
|
2017
|
123 |
S1 |
p. S330-
1 p.
|
artikel
|
| 1361 |
PO-0792: Monte-Carlo calculated energy deposition and nanodosimetric quantities around a gold nanoparticle
|
Dressel, T.
|
|
2017
|
123 |
S1 |
p. S421-
1 p.
|
artikel
|
| 1362 |
PO-0811: Monte Carlo simulation of peripheral dose for Gamma Knife treatments
|
Sanchez-Nieto, B.
|
|
2017
|
123 |
S1 |
p. S434-
1 p.
|
artikel
|
| 1363 |
PO-0895: MRI-based analysis of volumetric changes of healthy brain tissue in glioma patients after photon RT
|
Gommlich, A.
|
|
2017
|
123 |
S1 |
p. S493-S494
2 p.
|
artikel
|
| 1364 |
PO-0831: Multi isocentric 4-pi volumetric modulated arc therapy approach for head and neck cancer
|
Subramanian, S.
|
|
2017
|
123 |
S1 |
p. S447-
1 p.
|
artikel
|
| 1365 |
PO-0825: Multi-scenario sampling in robust proton therapy treatment planning
|
Sterpin, E.
|
|
2017
|
123 |
S1 |
p. S443-S444
2 p.
|
artikel
|
| 1366 |
PO-0917: Nationwide audit of small fields output calculations in Poland
|
Bulski, W.
|
|
2017
|
123 |
S1 |
p. S508-
1 p.
|
artikel
|
| 1367 |
PO-0929: Needle Migration in HDR Brachytherapy for Prostate Cancer evaluated by Serial MRI and Photos
|
Buus, S.
|
|
2017
|
123 |
S1 |
p. S515-
1 p.
|
artikel
|
| 1368 |
PO-0695: Neo-adjuvant chemoradiotherapy and resection for esophageal cancer: outcomes in daily practice.
|
Portier, E.S.H.
|
|
2017
|
123 |
S1 |
p. S363-S364
2 p.
|
artikel
|
| 1369 |
PO-0782: New liquid ionization chamber detector of high resolution for treatment verification in Radiotherapy
|
Brualla-Gonzalez, L.
|
|
2017
|
123 |
S1 |
p. S414-S415
2 p.
|
artikel
|
| 1370 |
PO-0778: New Razor silicon diode for Cyber Knife small beam relative dosimetry: a multi-site evaluation
|
Russo, S.
|
|
2017
|
123 |
S1 |
p. S412-S413
2 p.
|
artikel
|
| 1371 |
PO-0779: New robotic phantom for evaluation of imaging and radiotherapy of moving structures
|
Arenbeck, H.
|
|
2017
|
123 |
S1 |
p. S413-
1 p.
|
artikel
|
| 1372 |
PO-0646: Nodular Lymphocyte Predominant Hodgkin’s Lymphoma (NLPHL): Early Outcomes
|
Khanna, N.
|
|
2017
|
123 |
S1 |
p. S338-
1 p.
|
artikel
|
| 1373 |
PO-0729: Normal Tissue Complication Probability for late urinary toxicities after RT for prostate cancer
|
Palorini, F.
|
|
2017
|
123 |
S1 |
p. S382-S383
2 p.
|
artikel
|
| 1374 |
PO-0650: Omitting radiotherapy in triple-negative breast cancer leads to worse cancer-specific survival
|
Kindts, I.
|
|
2017
|
123 |
S1 |
p. S339-S340
2 p.
|
artikel
|
| 1375 |
PO-0684: Opposite pharmacokinetics of sorafenib modulates by liver irradiation - concurrent versus sequential
|
Hsieh, C.H.
|
|
2017
|
123 |
S1 |
p. S357-S358
2 p.
|
artikel
|
| 1376 |
PO-0796: Optimisation of plan robustness to sinus filling in a magnetic field
|
Pollitt, A.
|
|
2017
|
123 |
S1 |
p. S424-
1 p.
|
artikel
|
| 1377 |
PO-0676: outcomes of synchronous and metachronous pulmonary oligometastasis treated with SBRT
|
Sharma, A.
|
|
2017
|
123 |
S1 |
p. S353-S354
2 p.
|
artikel
|
| 1378 |
PO-0644: Overall survival following stereotactic radiosurgery (SRS) for breast cancer brain metastases
|
Patel, H.
|
|
2017
|
123 |
S1 |
p. S336-S337
2 p.
|
artikel
|
| 1379 |
PO-0660: Partial breast re-irradiation with IMRT in patients with local failure after conservative treatment
|
Dicuonzo, S.
|
|
2017
|
123 |
S1 |
p. S344-S345
2 p.
|
artikel
|
| 1380 |
PO-0620: Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiotherapy Regimen
|
Rock, K.
|
|
2017
|
123 |
S1 |
p. S324-
1 p.
|
artikel
|
| 1381 |
PO-0903: Patient-induced susceptibility effects simulation in magnetic resonance imaging
|
Lundman, J.A.
|
|
2017
|
123 |
S1 |
p. S499-
1 p.
|
artikel
|
| 1382 |
PO-0772: Patient-specific realtime error detection for VMAT based on transmission detector measurements
|
Pasler, M.
|
|
2017
|
123 |
S1 |
p. S409-
1 p.
|
artikel
|
| 1383 |
PO-0708: Patterns of Care in the Netherlands for Radiotherapy of Women with Locally Advanced Cervical Cancer
|
De Boer, P.
|
|
2017
|
123 |
S1 |
p. S371-
1 p.
|
artikel
|
| 1384 |
PO-0655: Patterns of locorégional failure in women with breast cancer treated by Postmastectomy Radiotherapy
|
Loganadane, G.
|
|
2017
|
123 |
S1 |
p. S342-
1 p.
|
artikel
|
| 1385 |
PO-0716: Pelvic insufficiency fracture after IMRT for gynecologic or anal cancer
|
Bazire, L.
|
|
2017
|
123 |
S1 |
p. S375-S376
2 p.
|
artikel
|
| 1386 |
PO-0915: Performance study of a prototype straight-through linac delivery system with an EPID assembly
|
Scheuermann, R.
|
|
2017
|
123 |
S1 |
p. S506-S507
2 p.
|
artikel
|
| 1387 |
PO-0686: Perfusion imaging of colorectal liver metastases treated with bevacizumab and SBRT
|
Chung, H.
|
|
2017
|
123 |
S1 |
p. S358-S359
2 p.
|
artikel
|
| 1388 |
PO-0839: Personalized VMAT optimization for pancreatic SBRT
|
Mihaylov, I.
|
|
2017
|
123 |
S1 |
p. S453-
1 p.
|
artikel
|
| 1389 |
PO-0890: PET-based radiobiological modeling of changes in tumor hypoxia during chemoradiotherapy
|
Crispin Ortuzar, M.
|
|
2017
|
123 |
S1 |
p. S489-S490
2 p.
|
artikel
|
| 1390 |
PO-0738: PET with 18F-Choline for evaluation of prostate cancer patients with biochemical relapse/persistence
|
Pérez Montero, H.
|
|
2017
|
123 |
S1 |
p. S388-S389
2 p.
|
artikel
|
| 1391 |
PO-0632: Phase I/II Trial on Intraoperative Radiotherapy (IORT) in Glioblastoma Multiforme (INTRAGO I/II)
|
Giordano, F.
|
|
2017
|
123 |
S1 |
p. S330-S331
2 p.
|
artikel
|
| 1392 |
PO-0698: Phase II study of induction chemotherapy followed by radiochemotherapy in pancreatic cancer
|
Fiore, M.
|
|
2017
|
123 |
S1 |
p. S365-S366
2 p.
|
artikel
|
| 1393 |
PO-0723: Phase II study with FFF linac-based SBRT in 5 fractions for localized prostate cancer
|
Alongi, F.
|
|
2017
|
123 |
S1 |
p. S379-
1 p.
|
artikel
|
| 1394 |
PO-0739: Phase II Trial of Dynamic Dosimetry for prostate brachytherapy: correlation with post-implant MRI/CT
|
|
|
2017
|
123 |
S1 |
p. S389-
1 p.
|
artikel
|
| 1395 |
PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers
|
Vendrely, V.
|
|
2017
|
123 |
S1 |
p. S367-S368
2 p.
|
artikel
|
| 1396 |
PO-0878: Plan adaptation on the MR-Linac: first dosimetric validation of a simple dose shift
|
Koopman, R.
|
|
2017
|
123 |
S1 |
p. S479-S480
2 p.
|
artikel
|
| 1397 |
PO-0783: Planverification in Robotic Stereotactic Radiotherapy with the Delta4-Dosimetry-System
|
Baus, W.
|
|
2017
|
123 |
S1 |
p. S415-
1 p.
|
artikel
|
| 1398 |
PO-0977: Plasma lipidomics for predictive biomarker analysis in rectal cancer
|
Bulens, P.
|
|
2017
|
123 |
S1 |
p. S540-S541
2 p.
|
artikel
|
| 1399 |
PO-0927: Plug-free needles provide dosimetric advantages over plugged needles in I-125 prostate brachytherapy
|
Mohamed Yoosuf, A.B.
|
|
2017
|
123 |
S1 |
p. S514-
1 p.
|
artikel
|
| 1400 |
PO-0694: Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma
|
Slim, N.
|
|
2017
|
123 |
S1 |
p. S362-S363
2 p.
|
artikel
|
| 1401 |
PO-0978: Potential predictive biomarkers to chemoradiotherapy response in rectal cancer: a lipidomic study
|
Perrotti, F.
|
|
2017
|
123 |
S1 |
p. S541-
1 p.
|
artikel
|
| 1402 |
PO-0807: Practical advantages of a transmission chamber in relative dosimetry of Brainlab conical applicators
|
Tang, B.
|
|
2017
|
123 |
S1 |
p. S431-
1 p.
|
artikel
|
| 1403 |
PO-0850: Predicting late fecal incontinence risk after RT for prostate cancer:external independent validation
|
Cicchetti, A.
|
|
2017
|
123 |
S1 |
p. S461-
1 p.
|
artikel
|
| 1404 |
PO-0956: Prediction of irradiated cells fate: the necessity to revisit RBE by multi-parametric investigations
|
Paget, V.
|
|
2017
|
123 |
S1 |
p. S528-S529
2 p.
|
artikel
|
| 1405 |
PO-0721: Prediction of local recurrence using pretreatment 18FDG PET/CT radiomics features in cervical cancer
|
Lucia, F.
|
|
2017
|
123 |
S1 |
p. S378-
1 p.
|
artikel
|
| 1406 |
PO-0627: Prediction of radiosurgery response of brain metastases using convolutional neural networks
|
Cha, Y.
|
|
2017
|
123 |
S1 |
p. S328-
1 p.
|
artikel
|
| 1407 |
PO-0848: Predictors of patient-reported incontinence after prostate cancer RT: results from a cohort study
|
Cozzarini, C.
|
|
2017
|
123 |
S1 |
p. S459-S460
2 p.
|
artikel
|
| 1408 |
PO-0765: Preparation and Fabrication of a Full-scale Patient-specific 3D-Printed Radiotherapy Phantom
|
Craft, D.
|
|
2017
|
123 |
S1 |
p. S404-S405
2 p.
|
artikel
|
| 1409 |
PO-0945: Pretreatment verification for brachytherapy
|
Fonseca, G.
|
|
2017
|
123 |
S1 |
p. S523-S524
2 p.
|
artikel
|
| 1410 |
PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients
|
Ou, D.
|
|
2017
|
123 |
S1 |
p. S533-S534
2 p.
|
artikel
|
| 1411 |
PO-0970: Prostate brachytherapy; DNA damage biomarker (gH2AX) induction rate correlates with late toxicity
|
Osman, S.
|
|
2017
|
123 |
S1 |
p. S535-S536
2 p.
|
artikel
|
| 1412 |
PO-0932: Prostate-specific Antigen bounce in patients treated with 125I prostate brachytherapy: Keep calm
|
Pires, A.
|
|
2017
|
123 |
S1 |
p. S516-S517
2 p.
|
artikel
|
| 1413 |
PO-0953: Proteome profiles in PDAC patients with local recurrence after postoperative radiochemotherapy
|
Bolm, L.
|
|
2017
|
123 |
S1 |
p. S527-
1 p.
|
artikel
|
| 1414 |
PO-0962: Proton minibeam irradiation leads to reduced acute side effects in an in-vivo mouse ear model
|
Zahnbrecher, E.
|
|
2017
|
123 |
S1 |
p. S531-S532
2 p.
|
artikel
|
| 1415 |
PO-0877: Proton therapy of oesophageal cancer is more robust against anatomical changes than photons
|
Møller, D.S.
|
|
2017
|
123 |
S1 |
p. S479-
1 p.
|
artikel
|
| 1416 |
PO-0882: Proxy-free slow-pitch helical 4DCT reconstruction
|
Werner, R.
|
|
2017
|
123 |
S1 |
p. S483-S484
2 p.
|
artikel
|
| 1417 |
PO-0835: PTV margin for pelvic lymph nodes in IGRT guided prostate radiotherapy
|
Jensen, H.R.
|
|
2017
|
123 |
S1 |
p. S450-
1 p.
|
artikel
|
| 1418 |
PO-0909: QA test of MLC speed using a fluorescent screen-CCD based dosimetry system
|
Yang, B.
|
|
2017
|
123 |
S1 |
p. S503-S504
2 p.
|
artikel
|
| 1419 |
PO-0891: Quality assessment of target volume delineation and dose planning in the Skagen Trial 1
|
Francolini, G.
|
|
2017
|
123 |
S1 |
p. S490-S491
2 p.
|
artikel
|
| 1420 |
PO-0607: Quality of life and xerostomia with IMRT versus 3D-CRT in postoperative head and neck radiotherapy
|
Van der Laan, H.P.
|
|
2017
|
123 |
S1 |
p. S316-S317
2 p.
|
artikel
|
| 1421 |
PO-0626: Quality of life: result from a randomized trial that compared WBRT with radiosurgery of tumor cavity
|
Kepka, L.
|
|
2017
|
123 |
S1 |
p. S327-S328
2 p.
|
artikel
|
| 1422 |
PO-0830: Quantification of density and tissue changes in pencil beam scanning proton treatment
|
Van den Heuvel, F.
|
|
2017
|
123 |
S1 |
p. S446-S447
2 p.
|
artikel
|
| 1423 |
PO-0900: Quantifying the Effect of MRI Geometrical Distortions on Radiotherapy Treatment Planning Doses
|
Adjeiwaah, M.
|
|
2017
|
123 |
S1 |
p. S497-
1 p.
|
artikel
|
| 1424 |
PO-0896: Quantitative MRI-based characterization of obturator muscles after prostate cancer radiotherapy
|
Scalco, E.
|
|
2017
|
123 |
S1 |
p. S494-S495
2 p.
|
artikel
|
| 1425 |
PO-0753: Radiation therapy and outcome in cancer patients with acute venous thromboembolism
|
Guy, J.B.
|
|
2017
|
123 |
S1 |
p. S397-
1 p.
|
artikel
|
| 1426 |
PO-0960: Radiobiological effectiveness and its role in modelling secondary cancer risk for proton therapy
|
Keisari, Y.
|
|
2017
|
123 |
S1 |
p. S530-S531
2 p.
|
artikel
|
| 1427 |
PO-0957: Radiobiological studies in in vitro reconstituted squamous epithelia
|
Zemora, G.
|
|
2017
|
123 |
S1 |
p. S529-
1 p.
|
artikel
|
| 1428 |
PO-0958: Radiogenomics: role of non-coding RNA genes in increased radiotherapy sensitivity
|
Duran-Lozano, L.
|
|
2017
|
123 |
S1 |
p. S529-S530
2 p.
|
artikel
|
| 1429 |
PO-0918: Radiotherapy and Her2 targeting agents: synergism and antagonism in clonogenic and confluence assays
|
Suchowerska, N.
|
|
2017
|
123 |
S1 |
p. S508-S509
2 p.
|
artikel
|
| 1430 |
PO-0733: Radium 223: Difference in clinical outcomes between young and old
|
Song, Y.P.
|
|
2017
|
123 |
S1 |
p. S385-
1 p.
|
artikel
|
| 1431 |
PO-0633: Randomized study of adjuvant temozolomide (6 vs.12 cycle) in newly diagnosed glioblastoma multiforme
|
Gandhi, A.K.
|
|
2017
|
123 |
S1 |
p. S331-
1 p.
|
artikel
|
| 1432 |
PO-0963: RBE variations along the Bragg curve of a 200MeV proton beam
|
Vandevoorde, C.
|
|
2017
|
123 |
S1 |
p. S532-
1 p.
|
artikel
|
| 1433 |
PO-0762: Real-time dosimetry with rare earth doped silica
|
Loi, G.
|
|
2017
|
123 |
S1 |
p. S402-S403
2 p.
|
artikel
|
| 1434 |
PO-0942: Real time in vivo dosimetry for cervix HDR brachytherapy - feasibility study using a MOSFET
|
Mason, J.
|
|
2017
|
123 |
S1 |
p. S521-S522
2 p.
|
artikel
|
| 1435 |
PO-0697: Reduced inter- and intra-observer variation in esophageal tumor delineation using fiducial markers.
|
Machiels, M.
|
|
2017
|
123 |
S1 |
p. S364-S365
2 p.
|
artikel
|
| 1436 |
PO-0833: Reducing small bowel dose for cervical cancer using IMPT and target tailoring in treatment planning
|
De Boer, P.
|
|
2017
|
123 |
S1 |
p. S448-S449
2 p.
|
artikel
|
| 1437 |
PO-1023: Reducing waiting room times - A 5 year review of an in-house KPI tool
|
Wallis, A.
|
|
2017
|
123 |
S1 |
p. S564-
1 p.
|
artikel
|
| 1438 |
PO-0682: Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history
|
Jingu, K.
|
|
2017
|
123 |
S1 |
p. S357-
1 p.
|
artikel
|
| 1439 |
PO-0656: Reirradiation+hyperthermia after surgery for recurrent breast cancer: 70% 5-year local control
|
Oldenborg, S.
|
|
2017
|
123 |
S1 |
p. S342-S343
2 p.
|
artikel
|
| 1440 |
PO-1020: Re-irradiation of Head and Neck Sarcomas: initial results of Protontherapy Center of Trento, Italy
|
Giacomelli, I.
|
|
2017
|
123 |
S1 |
p. S563-
1 p.
|
artikel
|
| 1441 |
PO-0804: Relative dosimetry evaluation for small multileaf collimator fields on a TrueBeam linear accelerator
|
Younes, T.
|
|
2017
|
123 |
S1 |
p. S429-
1 p.
|
artikel
|
| 1442 |
PO-0907: Remote auditing of IMRT/VMAT deliveries
|
Miri, N.
|
|
2017
|
123 |
S1 |
p. S502-
1 p.
|
artikel
|
| 1443 |
PO-0959: REQUITE: Radiation Induced Lymphocyte Apoptosis assay as a predictor for radiotherapy side effects
|
Talbot, C.
|
|
2017
|
123 |
S1 |
p. S530-
1 p.
|
artikel
|
| 1444 |
PO-0872: Respiration motion management strategy for sparing of risk organs in esophagus cancer radiotherapy
|
Biancardo, S.B.N.
|
|
2017
|
123 |
S1 |
p. S475-S476
2 p.
|
artikel
|
| 1445 |
PO-0888: Response monitoring by 18FDG-PET in locally advanced NSCLC treated with concurrent chemoradiotherapy
|
Van Diessen, J.N.A.
|
|
2017
|
123 |
S1 |
p. S488-
1 p.
|
artikel
|
| 1446 |
PO-0743: Retransplantation of bony autografts sterilized by extracorporal high dose irradiation
|
Saleh-Ebrahimi, L.
|
|
2017
|
123 |
S1 |
p. S391-
1 p.
|
artikel
|
| 1447 |
PO-0767: Revisiting EPID design for modern radiotherapy requirements
|
Vial, P.
|
|
2017
|
123 |
S1 |
p. S406-
1 p.
|
artikel
|
| 1448 |
PO-0652: Risk factors for complications of post-mastectomy radiotherapy on implant-based reconstructed breast
|
Ogita, M.
|
|
2017
|
123 |
S1 |
p. S340-S341
2 p.
|
artikel
|
| 1449 |
PO-0711: Risk factors for insufficiency fractures in cervix cancer following intensity modulated radiotherapy
|
Ramlov, A.
|
|
2017
|
123 |
S1 |
p. S372-S373
2 p.
|
artikel
|
| 1450 |
PO-0827: Robustness Evaluation of Head and Neck Treatment with Proton Pencil Beam Scanning Technique
|
Lin, H.
|
|
2017
|
123 |
S1 |
p. S444-S445
2 p.
|
artikel
|
| 1451 |
PO-0819: Robustness evaluation of single- and multifield optimized proton plans for unilateral head and neck
|
Cubillos Mesías, M.
|
|
2017
|
123 |
S1 |
p. S438-S439
2 p.
|
artikel
|
| 1452 |
PO-0829: Robustness of IMRT and VMAT for interfraction motion in locoregional breast irradiation
|
Canters, R.
|
|
2017
|
123 |
S1 |
p. S445-S446
2 p.
|
artikel
|
| 1453 |
PO-0679: Role of Chemoradiation Therapy as an Initial Treatment for Esophageal Carcinoma: A Meta-Analysis
|
Ma, M.
|
|
2017
|
123 |
S1 |
p. S355-
1 p.
|
artikel
|
| 1454 |
PO-0948: Role of HDR Intraluminal Brachytherapy in carcinoma Esophagus: An institutional experience
|
Kainthaje, P.B.
|
|
2017
|
123 |
S1 |
p. S525-
1 p.
|
artikel
|
| 1455 |
PO-0618: Role of PET in radiotherapy planning of head and neck tumors: a systematic review
|
Ferioli, M.
|
|
2017
|
123 |
S1 |
p. S323-
1 p.
|
artikel
|
| 1456 |
PO-0717: Role of Radiation Therapy in Vulvar Cancer Patients with One or More Positive Inguinal Lymph Nodes
|
Kanis, M.J.
|
|
2017
|
123 |
S1 |
p. S376-
1 p.
|
artikel
|
| 1457 |
PO-0674: SABR for lung tumors of 5cm or more: can knowledge-based planning detect high-risk treatment plans?
|
Van 't Hof, S.
|
|
2017
|
123 |
S1 |
p. S352-S353
2 p.
|
artikel
|
| 1458 |
PO-0680: SBRT for locally advanced pancreatic cancer (LAPC): a retrospective multi-institutional experience
|
Macchia, G.
|
|
2017
|
123 |
S1 |
p. S355-S356
2 p.
|
artikel
|
| 1459 |
PO-0681: SBRT VS standard chemoradiation in locally advanced pancreatic cancer (LAPC): a case-control study
|
Arcelli, A.
|
|
2017
|
123 |
S1 |
p. S356-
1 p.
|
artikel
|
| 1460 |
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer
|
Scoccianti, S.
|
|
2017
|
123 |
S1 |
p. S336-
1 p.
|
artikel
|
| 1461 |
PO-0905: (Semi-)Automatic contouring strategies for rectal boost treatment on the MR-Linac
|
Nomden, C.N.
|
|
2017
|
123 |
S1 |
p. S500-S501
2 p.
|
artikel
|
| 1462 |
PO-0747: Setting defaults in palliative radiation: a value-driven approach to improving care
|
Puckett, L.
|
|
2017
|
123 |
S1 |
p. S393-S394
2 p.
|
artikel
|
| 1463 |
PO-0912: Short- and long term stability of the isocenter of a three-source Co60 MR guided radiotherapy device
|
Hoffmans, D.
|
|
2017
|
123 |
S1 |
p. S505-
1 p.
|
artikel
|
| 1464 |
PO-0938: Should we use point A dose for image-guided adaptive brachytherapy reporting in cervix cancer?
|
Mazeron, R.
|
|
2017
|
123 |
S1 |
p. S519-
1 p.
|
artikel
|
| 1465 |
PO-0725: Sigmoid colon is an important organ at risk for high-grade faecal urgency after pelvic radiotherapy
|
Jadon, R.
|
|
2017
|
123 |
S1 |
p. S380-
1 p.
|
artikel
|
| 1466 |
PO-0612: Significance of co-expression of mutant p53 protein and Ki67 in locally advanced HNSCC post chemo-RT
|
Baskaran Shanmuga, P.
|
|
2017
|
123 |
S1 |
p. S319-
1 p.
|
artikel
|
| 1467 |
PO-0700: Significant heart dose reduction by deep inspiration breath hold for RT of esophageal cancer
|
Dieters, M.
|
|
2017
|
123 |
S1 |
p. S366-S367
2 p.
|
artikel
|
| 1468 |
PO-0687: Spleen dosimetry are associated with lymphopenia during radiotherapy for hepatocellular carcinoma
|
Zhao, Q.
|
|
2017
|
123 |
S1 |
p. S359-
1 p.
|
artikel
|
| 1469 |
PO-0664: Standardized Nodal Radiation (RT) through a Breast Clinical Pathway (CP) within a USA Cancer Network
|
Gebhardt, B.
|
|
2017
|
123 |
S1 |
p. S347-S348
2 p.
|
artikel
|
| 1470 |
PO-0828: Stereotactic body radiotherapy (SBRT) for localised prostate cancer on the MR-Linac
|
Pathmanathan, A.
|
|
2017
|
123 |
S1 |
p. S445-
1 p.
|
artikel
|
| 1471 |
PO-0919: Stereotactic radiotherapy for brain metastases : Cyberknife versus VersaHD / ExacTrac
|
Perdrieux, M.
|
|
2017
|
123 |
S1 |
p. S509-
1 p.
|
artikel
|
| 1472 |
PO-0693: Stereotactic radiotherapy in hepatocellular carcinoma: a systematic review
|
Manuzzi, L.
|
|
2017
|
123 |
S1 |
p. S362-
1 p.
|
artikel
|
| 1473 |
PO-0797: Studies on optical fiber dosimeters for in-vivo dosimetry in HDR brachytherapy
|
Moutinho, L.
|
|
2017
|
123 |
S1 |
p. S424-S425
2 p.
|
artikel
|
| 1474 |
PO-0871: Study of the effect of heterogeneous setup random errors in treatment margins
|
Sevillano, D.
|
|
2017
|
123 |
S1 |
p. S474-S475
2 p.
|
artikel
|
| 1475 |
PO-0989: Sub-lethal radiation allows an efficient antitumor therapy with engineered T-cells in RIP-Tag2 mice
|
Maione, F.
|
|
2017
|
123 |
S1 |
p. S545-S546
2 p.
|
artikel
|
| 1476 |
PO-0863: Suggestion of optimal planning target volume margins for stereotactic body radiotherapy of the spine
|
Jeon, S.H.
|
|
2017
|
123 |
S1 |
p. S469-S470
2 p.
|
artikel
|
| 1477 |
PO-0740: Surgery versus Radiotherapy in Uveal Melanoma: SEER Analysis using Propensity Score Matching & IPTW
|
Jang, B.S.
|
|
2017
|
123 |
S1 |
p. S389-
1 p.
|
artikel
|
| 1478 |
PO-0722: Symptomatic pelvic insufficiency fracture in women after pelvic RT- is there a dosimetric correlate?
|
Horne, Z.
|
|
2017
|
123 |
S1 |
p. S378-S379
2 p.
|
artikel
|
| 1479 |
PO-0856: Systematic baseline shifts of lymph node targets between setup and treatment of lung cancer patients
|
Schmidt, M.L.
|
|
2017
|
123 |
S1 |
p. S465-S466
2 p.
|
artikel
|
| 1480 |
PO-0742: Target delineation conformity in extremity STS within the UK phase II multi-centre IMRiS trial
|
Yang, H.
|
|
2017
|
123 |
S1 |
p. S390-S391
2 p.
|
artikel
|
| 1481 |
PO-0662: Target therapy and hypofractionated whole breast radiotherapy: an unexpected protective factor
|
De Santis, M.C.
|
|
2017
|
123 |
S1 |
p. S345-S346
2 p.
|
artikel
|
| 1482 |
PO-1014: Target volume motion during anal cancer IGRT using cone-beam CT
|
Brooks, C.
|
|
2017
|
123 |
S1 |
p. S559-S560
2 p.
|
artikel
|
| 1483 |
PO-0906: Textural analysis of MR images to improve the characterisation of recurrent prostate cancer
|
Stirling, J.
|
|
2017
|
123 |
S1 |
p. S501-S502
2 p.
|
artikel
|
| 1484 |
PO-0667: The differences between two groups of patients with NSCLC depending on the imaging for radiotherapy
|
Masarykova, A.
|
|
2017
|
123 |
S1 |
p. S349-
1 p.
|
artikel
|
| 1485 |
PO-0770: The distortions of the dose response functions of dosimeters in the presence of a magnetic field
|
Looe, H.K.
|
|
2017
|
123 |
S1 |
p. S407-S408
2 p.
|
artikel
|
| 1486 |
PO-0847: The dose-response curve of post-treatment FDG-uptake in lung tissue of irradiated NSCLC patients
|
La Fontaine, M.
|
|
2017
|
123 |
S1 |
p. S458-S459
2 p.
|
artikel
|
| 1487 |
PO-0771: The dose response functions of an air-filled ionization chamber in the presence of a magnetic field
|
Delfs, B.
|
|
2017
|
123 |
S1 |
p. S408-
1 p.
|
artikel
|
| 1488 |
PO-0766: The effect of air gaps on Magic Plate (MP512) for small field dosimetry
|
Utitsarn, K.
|
|
2017
|
123 |
S1 |
p. S405-
1 p.
|
artikel
|
| 1489 |
PO-0734: The effect of TAB duration and pelvic RT in prostate cancers with gleason score 8-10: TROG study
|
Ozyigit, G.
|
|
2017
|
123 |
S1 |
p. S386-
1 p.
|
artikel
|
| 1490 |
PO-1007: The effect of VMAT on tumor coverage and organs at risk for head and neck cancer patients
|
Kertevig, M.
|
|
2017
|
123 |
S1 |
p. S555-
1 p.
|
artikel
|
| 1491 |
PO-0874: The impact of rectal filing on rectal tumor position
|
Kleijnen, J.J.E.
|
|
2017
|
123 |
S1 |
p. S476-S477
2 p.
|
artikel
|
| 1492 |
PO-0832: The impact of variable RBE and breathing control in proton radiotherapy of breast cancer
|
Odén, J.
|
|
2017
|
123 |
S1 |
p. S447-S448
2 p.
|
artikel
|
| 1493 |
PO-0730: The independent benefit deriving from high doses and WPRT in salvage post-prostatectomy radiotherapy
|
Cozzarini, C.
|
|
2017
|
123 |
S1 |
p. S383-S384
2 p.
|
artikel
|
| 1494 |
PO-0814: The Influence of scans parameters on effective dose of CBCT scans used for IGRT proce dures
|
Abuhaimed,
|
|
2017
|
123 |
S1 |
p. S435-S436
2 p.
|
artikel
|
| 1495 |
PO-0645: The patterns of the relapses of aggressive non-hodgkin lymphomas after chemoradiotherapy
|
Sotnikov, V.
|
|
2017
|
123 |
S1 |
p. S337-S338
2 p.
|
artikel
|
| 1496 |
PO-0614: The prognostic role of 18F-FDG PET/CT in head and neck cancer and the importance of HPV status
|
Moan, J.M.
|
|
2017
|
123 |
S1 |
p. S320-S321
2 p.
|
artikel
|
| 1497 |
PO-0776: Thermoluminescence Characteristics of Fabricated Ge Doped Optical Fibre for Radiotherapy Dosimetry
|
Ahmad Fadzil, M.S.
|
|
2017
|
123 |
S1 |
p. S411-
1 p.
|
artikel
|
| 1498 |
PO-0692: The role of adjuvant chemoradiotherapy in patients with common bile duct cancer after R1 resection
|
Kim, S.W.
|
|
2017
|
123 |
S1 |
p. S361-
1 p.
|
artikel
|
| 1499 |
PO-0968: The Role of epithelial to mesenchymal transition (EMT) as Biomarker for Radioresistance in HNSCC
|
Kurth, I.
|
|
2017
|
123 |
S1 |
p. S534-S535
2 p.
|
artikel
|
| 1500 |
PO-0630: The role of mc4r gene polymorphisms in gbm patients treated with concomitant radio-chemotherapy
|
Cantarella, M.
|
|
2017
|
123 |
S1 |
p. S329-S330
2 p.
|
artikel
|
| 1501 |
PO-0665: The role of post-mastectomy radiotherapy (PMRT) and prognostic factors of locoregional recurrence
|
Delishaj, D.
|
|
2017
|
123 |
S1 |
p. S348-
1 p.
|
artikel
|
| 1502 |
PO-0719: The use of ultrasound bladder scanning in cervical IMRT to reduce variability of uterine motion
|
Otter, S.
|
|
2017
|
123 |
S1 |
p. S377-
1 p.
|
artikel
|
| 1503 |
PO-0685: The value of postoperative adjuvant therapy for pT2-3 esophageal cancer treated by radical resection
|
Zhu, S.
|
|
2017
|
123 |
S1 |
p. S358-
1 p.
|
artikel
|
| 1504 |
PO-0773: Three-dimensional radiation dosimetry based on optically-stimulated luminescence
|
Sadel, M.
|
|
2017
|
123 |
S1 |
p. S409-S410
2 p.
|
artikel
|
| 1505 |
PO-0925: Timing of post-implant analysis in permanent breast seed implant: results from a serial CT study
|
Watt, E.
|
|
2017
|
123 |
S1 |
p. S512-S513
2 p.
|
artikel
|
| 1506 |
PO-0714: Toxicity and Clinical Outcome of IMRT versus Conventional Radiation Therapy for Endometrial Cancer
|
Vaalavirta, L.
|
|
2017
|
123 |
S1 |
p. S375-
1 p.
|
artikel
|
| 1507 |
PO-0732: Toxicity and outcome in moderately hypofractionated radiotherapy for 590 prostate cancer patients
|
Maucieri, A.
|
|
2017
|
123 |
S1 |
p. S384-S385
2 p.
|
artikel
|
| 1508 |
PO-1012: Traffic Light Protocol as a guide for optimal registration of LACC complex tumor pathology
|
Bogaert, E.
|
|
2017
|
123 |
S1 |
p. S558-
1 p.
|
artikel
|
| 1509 |
PO-0876: Treatment adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer
|
Hoffmann, L.
|
|
2017
|
123 |
S1 |
p. S478-S479
2 p.
|
artikel
|
| 1510 |
PO-0838: Treatment planning for the MR-linac: plan quality compared with current clinical practice
|
Van de Schoot, A.J.A.J.
|
|
2017
|
123 |
S1 |
p. S452-S453
2 p.
|
artikel
|
| 1511 |
PO-0849: Trismus after chemoradiation in head & neck cancer: relation with medial pterygoid and masseter dose
|
Hamming-Vrieze, O.
|
|
2017
|
123 |
S1 |
p. S460-S461
2 p.
|
artikel
|
| 1512 |
PO-0985: Tumor metabolic changes after neoadjuvant radiotherapy: consequences for surgery-related metastases
|
Leroi, N.
|
|
2017
|
123 |
S1 |
p. S544-
1 p.
|
artikel
|
| 1513 |
PO-0899: Tumor volume delineation using non-EPI diffusion weighted MRI and FDG-PET in he ad-and-neck patients
|
Peltenburg, B.
|
|
2017
|
123 |
S1 |
p. S496-S497
2 p.
|
artikel
|
| 1514 |
PO-0688: Unresectable hepatic oligorecurrence SBRT of 55 lesion: Adequate dose coverage improves local control
|
Berkovic, P.
|
|
2017
|
123 |
S1 |
p. S359-S360
2 p.
|
artikel
|
| 1515 |
PO-0751: Uptake of a novel interactive 3D web-based contouring atlas among the radiation oncology community
|
Gillespie, E.
|
|
2017
|
123 |
S1 |
p. S396-
1 p.
|
artikel
|
| 1516 |
PO-0933: Urethral dose in cervical image guided brachytherapy
|
MacLennan, K.
|
|
2017
|
123 |
S1 |
p. S517-
1 p.
|
artikel
|
| 1517 |
PO-0855: Use of the LKB model to fit urethral strictures for prostate patients treated with HDRB
|
Panettieri, V.
|
|
2017
|
123 |
S1 |
p. S465-
1 p.
|
artikel
|
| 1518 |
PO-0880: Using accumulated delivered dose to predict rectal toxicity in prostate radiotherapy
|
Shelley, L.E.A.
|
|
2017
|
123 |
S1 |
p. S481-S482
2 p.
|
artikel
|
| 1519 |
PO-0920: Utilizing monte carlo for log file-based delivery QA
|
Stanhope, C.
|
|
2017
|
123 |
S1 |
p. S509-S510
2 p.
|
artikel
|
| 1520 |
PO-0759: Validation of the influence of M512 substrate resistivity on sensitivity degradation of radiation
|
Stansook, N.
|
|
2017
|
123 |
S1 |
p. S400-S401
2 p.
|
artikel
|
| 1521 |
PO-0621: Validation of tumor delineation on HE stained sections with cytokeratin staining as gold standard
|
Ligtenberg, H.
|
|
2017
|
123 |
S1 |
p. S324-S325
2 p.
|
artikel
|
| 1522 |
PO-0757: Variation of mean dose output from 204 UK linacs (Jan-June 2015) and its potential clinical impact
|
Bolt, M.
|
|
2017
|
123 |
S1 |
p. S399-
1 p.
|
artikel
|
| 1523 |
PO-0941: Verifying the treatment planning system in individualized HDR brachytherapy of cervical cancer
|
Van den Bosch, M.
|
|
2017
|
123 |
S1 |
p. S521-
1 p.
|
artikel
|
| 1524 |
PO-0677: Vero SBRT for early stage lung cancer: a phase II trial with dynamic tracking in selected lesions
|
Collen, C.
|
|
2017
|
123 |
S1 |
p. S354-
1 p.
|
artikel
|
| 1525 |
PO-0866: Visibility, image artifacts and proton dose perturbation of fiducial markers
|
Hamming, V.C.
|
|
2017
|
123 |
S1 |
p. S471-S472
2 p.
|
artikel
|
| 1526 |
PO-0784: Volume correction factors for alanine dosimetry in small MV photon fields
|
Riis, H.L.
|
|
2017
|
123 |
S1 |
p. S415-S416
2 p.
|
artikel
|
| 1527 |
PO-0843: volumetric-modulated Dynamic WaveArc therapy reduces the doses to the hippocampus
|
Uto, M.
|
|
2017
|
123 |
S1 |
p. S455-S456
2 p.
|
artikel
|
| 1528 |
PO-0640: Which measurement type should be used for disease control of brain metastasis, volumetric or linear?
|
Fischedick, A.
|
|
2017
|
123 |
S1 |
p. S335-
1 p.
|
artikel
|
| 1529 |
PO-0691: Whole-body total lesion glycolysis is an independent predictor of thoracic esophageal cancer
|
Takahashi, N.
|
|
2017
|
123 |
S1 |
p. S361-
1 p.
|
artikel
|
| 1530 |
PO-0705: Work ability in Dutch rectal cancer patients during the first year of treatment
|
Couwenberg, A.M.
|
|
2017
|
123 |
S1 |
p. S369-S370
2 p.
|
artikel
|
| 1531 |
PV-0423: AAPM TG-158 recommendations for neutron dosimetry for photon, electron, and light-ion therapy
|
Howell, R.
|
|
2017
|
123 |
S1 |
p. S223-
1 p.
|
artikel
|
| 1532 |
PV-0240: A logistic regression model to predict 30-day mortality: difference between routine and trial data
|
Jochems, A.
|
|
2017
|
123 |
S1 |
p. S120-S121
2 p.
|
artikel
|
| 1533 |
PV-0233: A Radiosensitivity Gene Signature & PD-L1 Predict Clinical Outcome of Breast Cancer in TCGA dataset
|
Jang, B.S.
|
|
2017
|
123 |
S1 |
p. S117-
1 p.
|
artikel
|
| 1534 |
PV-0050: A randomised controlled study of decision aids to improve clinical trial decisions & recruitment
|
Sundaresan, P.
|
|
2017
|
123 |
S1 |
p. S22-
1 p.
|
artikel
|
| 1535 |
PV-0505: Association between the diagnosis-to-treatment interval and overall survival in Taiwan OSCC
|
Liao, C.T.
|
|
2017
|
123 |
S1 |
p. S266-
1 p.
|
artikel
|
| 1536 |
PV-0093: Availability of radiotherapy in Africa: past and present of an unsolved problem
|
Zubizarreta, E.H.
|
|
2017
|
123 |
S1 |
p. S48-
1 p.
|
artikel
|
| 1537 |
PV-0418: Characterisation of the prototype plastic scintillation detector (PSD) in a strong magnetic field
|
Asghar, M.
|
|
2017
|
123 |
S1 |
p. S220-
1 p.
|
artikel
|
| 1538 |
PV-0550: Combined high dose radiation and tyrosine kinase inhibitors in renal cell carcinoma: a phase I trial
|
De Wolf, K.
|
|
2017
|
123 |
S1 |
p. S293-S294
2 p.
|
artikel
|
| 1539 |
PV-0241: Comparing endpoints of radiation induced lung injury for NSCLC: radiology vs. clinical symptoms
|
Bernchou, U.
|
|
2017
|
123 |
S1 |
p. S121-S122
2 p.
|
artikel
|
| 1540 |
PV-0506: Comparison of Clinical Behavior of Viral Related Oropharyngeal and Nasopharyngeal Carcinoma
|
Huang, S.H.
|
|
2017
|
123 |
S1 |
p. S266-S267
2 p.
|
artikel
|
| 1541 |
PV-0460: Comparison of 3 Image-guided Adaptive Strategies for Bladder Radiotherapy
|
Kong, V.
|
|
2017
|
123 |
S1 |
p. S245-
1 p.
|
artikel
|
| 1542 |
PV-0132: Comparison of planned versus simulated delivered dose in IMRT for endometrial cancer
|
White, I.
|
|
2017
|
123 |
S1 |
p. S62-S63
2 p.
|
artikel
|
| 1543 |
PV-0046: Comparison of respiratory-induced diaphragm motion during radiotherapy between children and adults
|
Huijskens, S.
|
|
2017
|
123 |
S1 |
p. S20-
1 p.
|
artikel
|
| 1544 |
PV-0092: Criterion-Based Benchmarking approach of the appropriate use of radiotherapy in NSW-ACT, Australia
|
Gabriel, G.
|
|
2017
|
123 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 1545 |
PV-0457: Delay between planning and stereotactic radiotherapy for brain metastases: margins still accurate?
|
Bonnet, C.
|
|
2017
|
123 |
S1 |
p. S243-
1 p.
|
artikel
|
| 1546 |
PV-0287: Determination of MC-based predictive models for personalized and fast kV-CBCT organ dose estimation
|
Chesneau, H.
|
|
2017
|
123 |
S1 |
p. S151-
1 p.
|
artikel
|
| 1547 |
PV-0323: Development of a prognostic model incorporating PET texture analysis in oesophageal cancer patients
|
Foley, K.
|
|
2017
|
123 |
S1 |
p. S169-
1 p.
|
artikel
|
| 1548 |
PV-0422: Direct determination of kQ in a clinical carbon ion beam using water calorimetry
|
Osinga-Blättermann, J.M.
|
|
2017
|
123 |
S1 |
p. S223-
1 p.
|
artikel
|
| 1549 |
PV-0284: 3D Performance Analysis of Cyberknife Synchrony® Respiratory Tracking System
|
Sahin, M.C.
|
|
2017
|
123 |
S1 |
p. S149-
1 p.
|
artikel
|
| 1550 |
PV-0462: E-learning in the Radiotherapy Department- Ortello
|
De Jong, J.P.
|
|
2017
|
123 |
S1 |
p. S246-
1 p.
|
artikel
|
| 1551 |
PV-0373: Epigenetic and metabolic reprogramming as a target for prostate tumor radiosensitization
|
Dubrovska, A.
|
|
2017
|
123 |
S1 |
p. S201-
1 p.
|
artikel
|
| 1552 |
PV-0045: Estimation of internal risk volume for coronary arteries after motion evaluation with ECG-gated CT
|
Levis, M.
|
|
2017
|
123 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 1553 |
PV-0328: Factors associated with complete response after brachytherapy for rectal cancer; the HERBERT study
|
Rijkmans, E.C.
|
|
2017
|
123 |
S1 |
p. S172-S173
2 p.
|
artikel
|
| 1554 |
PV-0509: Failure type specific prognostic model for selection of HNSCC patients for experimental treatments
|
Håkansson, K.
|
|
2017
|
123 |
S1 |
p. S268-S269
2 p.
|
artikel
|
| 1555 |
PV-0324: FDG-PET based pelvic bone marrow dose predicts for blood cell nadirs in CT-RT for anal cancer
|
Franco, P.
|
|
2017
|
123 |
S1 |
p. S169-S170
2 p.
|
artikel
|
| 1556 |
PV-0511: Fitting NTCP models to patient reported xerostomia and dysphagia after H & N radiotherapy to 60Gy
|
Mavroidis, P.
|
|
2017
|
123 |
S1 |
p. S269-S270
2 p.
|
artikel
|
| 1557 |
PV-0458: FMECA of Cyberknife process: two years’ experience for improvement
|
Cucchiaro, S.
|
|
2017
|
123 |
S1 |
p. S243-S244
2 p.
|
artikel
|
| 1558 |
PV-0510: FMISO-PET/CT and functional MRI parameters as biomarkers during chemoradiation of HNSCC
|
Bunea, H.
|
|
2017
|
123 |
S1 |
p. S269-
1 p.
|
artikel
|
| 1559 |
PV-0042: Fractionated-TBI schedules prior to allograft: Study from the Acute Leukemia Working Party (EBMT)
|
Belkacemi, Y.
|
|
2017
|
123 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 1560 |
PV-0283: Gated liver SBRT based on internal electromagnetic motion monitoring
|
Worm, E.
|
|
2017
|
123 |
S1 |
p. S148-S149
2 p.
|
artikel
|
| 1561 |
PV-0088: Half body irradiation schedule in patients with multiple bone metastases: a phase I-II trial
|
Ferro, M.
|
|
2017
|
123 |
S1 |
p. S45-
1 p.
|
artikel
|
| 1562 |
PV-0372: Histology-specific quantitative mapping and targeting of glucose and glutamine metabolism in NSCLC
|
Meijer, T.W.H.
|
|
2017
|
123 |
S1 |
p. S200-S201
2 p.
|
artikel
|
| 1563 |
PV-0236: Impact of radiation therapy delay in patients underwent neoadjuvant chemotherapy and breast surgery
|
Silva, S.
|
|
2017
|
123 |
S1 |
p. S118-S119
2 p.
|
artikel
|
| 1564 |
PV-0188: Improved class solutions for prostate brachytherapy planning via evolutionary machine learning
|
Maree, S.C.
|
|
2017
|
123 |
S1 |
p. S96-S97
2 p.
|
artikel
|
| 1565 |
PV-0087: Improvement of models for survival prediction through inclusion of patient-reported symptoms
|
Nieder, C.
|
|
2017
|
123 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 1566 |
PV-0421: In-magnet measurement setup for proof-of-concept and commissioning of MR integrated proton therapy
|
Lühr, A.
|
|
2017
|
123 |
S1 |
p. S221-S222
2 p.
|
artikel
|
| 1567 |
PV-0461: Integrating diagnostic MRI in radical bladder cancer radiotherapy: Challenges in image registration
|
Eccles, C.L.
|
|
2017
|
123 |
S1 |
p. S245-S246
2 p.
|
artikel
|
| 1568 |
PV-0044: Is involved-node radiotherapy for Hodgkin lymphoma safe in routine?
|
Boros, A.
|
|
2017
|
123 |
S1 |
p. S19-
1 p.
|
artikel
|
| 1569 |
PV-0134: Isotoxic stereotactic radiotherapy for central pelvic recurrence in gynecological cancer
|
Llewelyn, M.
|
|
2017
|
123 |
S1 |
p. S64-
1 p.
|
artikel
|
| 1570 |
PV-0235: Is there a subset who benefits from PMRT in node-negative breast cancer patients?
|
Park, H.J.
|
|
2017
|
123 |
S1 |
p. S118-
1 p.
|
artikel
|
| 1571 |
PV-0420: Learn before you measure: Method of single-isolated errors analysis for ArcCheck
|
Gizynska, M.
|
|
2017
|
123 |
S1 |
p. S221-S222
2 p.
|
artikel
|
| 1572 |
PV-0136: Linear energy transfer in normal tissues in spot scanning proton therapy of pro state cancer
|
Pedersen, J.
|
|
2017
|
123 |
S1 |
p. S64-S65
2 p.
|
artikel
|
| 1573 |
PV-0281: Lymph node MRI in regional breast radiotherapy leads to smaller target volumes and lower OAR dose
|
Van Heijst, T.
|
|
2017
|
123 |
S1 |
p. S146-S147
2 p.
|
artikel
|
| 1574 |
PV-0237: Management and outcome of local failure after intraoperative partial breast irradiation
|
Leonardi, M.C.
|
|
2017
|
123 |
S1 |
p. S119-
1 p.
|
artikel
|
| 1575 |
PV-0186: MaxiCalc: a tool to calculate dose distributions from measured source positions in HDR brachytherapy
|
Hanlon, M.
|
|
2017
|
123 |
S1 |
p. S95-
1 p.
|
artikel
|
| 1576 |
PV-0183: Microbrachytherapy: even more localised dose profiles?
|
Brown, R.
|
|
2017
|
123 |
S1 |
p. S93-S94
2 p.
|
artikel
|
| 1577 |
PV-0370: MicroRNA-200c radiosensitizes Human Cancer Cells with Activated EGFR or HER2-associated Signaling
|
Kim, I.A.
|
|
2017
|
123 |
S1 |
p. S199-S200
2 p.
|
artikel
|
| 1578 |
PV-0374: Molecular insights into a disease-relevant DNA damage response pathway
|
Xu, B.
|
|
2017
|
123 |
S1 |
p. S201-S202
2 p.
|
artikel
|
| 1579 |
PV-0321: MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer
|
Heerkens, H.D.
|
|
2017
|
123 |
S1 |
p. S167-S168
2 p.
|
artikel
|
| 1580 |
PV-0131: MR-only prostate external radiotherapy treatment planning - a multi-center/multi-vendor validation
|
Persson, E.
|
|
2017
|
123 |
S1 |
p. S62-
1 p.
|
artikel
|
| 1581 |
PV-0549: National Cancer Data Base Analysis of SBRT, IMRT, and Brachytherapy Boost for Cervical Cancer
|
Ludwig, M.
|
|
2017
|
123 |
S1 |
p. S292-S293
2 p.
|
artikel
|
| 1582 |
PV-0507: NGS for prognostic stratification in oral cancer harboring lymph node without extracapsular spread
|
Wang, H.M.
|
|
2017
|
123 |
S1 |
p. S267-
1 p.
|
artikel
|
| 1583 |
PV-0416: Novel methods for normal tissue dose in epidemiological studies of second cancer in radiotherapy
|
Lee, C.
|
|
2017
|
123 |
S1 |
p. S219-S220
2 p.
|
artikel
|
| 1584 |
PV-0371: Novel molecular radiobiology for personalised prostate cancer radiotherapy
|
McDermott, N.
|
|
2017
|
123 |
S1 |
p. S200-
1 p.
|
artikel
|
| 1585 |
PV-0503: Novel RPA classification combining MGMT promoter methylation status in newly diagnosed glioblastoma
|
Wee, C.W.
|
|
2017
|
123 |
S1 |
p. S265-
1 p.
|
artikel
|
| 1586 |
PV-0504: Observed survival in 3270 patients treated with Whole Brain Radiotherapy compared to the QUARTZ data
|
Jeene, P.
|
|
2017
|
123 |
S1 |
p. S265-S266
2 p.
|
artikel
|
| 1587 |
PV-0282: Out-of-plane motion correction in orthogonal cine-MRI registration
|
Seregni, M.
|
|
2017
|
123 |
S1 |
p. S147-S148
2 p.
|
artikel
|
| 1588 |
PV-0554: Patient-reported outcomes from the phase III prostate HYPRO trial: urinary toxicity
|
Wortel, R.C.
|
|
2017
|
123 |
S1 |
p. S295-S297
3 p.
|
artikel
|
| 1589 |
PV-0138: Pencil beam scanning treatments in free-breathing lung cancer patients – is 5 mm motion a limit?
|
Jakobi, A.
|
|
2017
|
123 |
S1 |
p. S66-S67
2 p.
|
artikel
|
| 1590 |
PV-0502: Post-operative radiation therapy in atypical meningiomas: analysis of prognostic factors
|
Shakir, S.
|
|
2017
|
123 |
S1 |
p. S264-S265
2 p.
|
artikel
|
| 1591 |
PV-0048: Prognostic impact of tumor size and response in neoadjuvant radiotherapy of soft tissue sarcoma
|
Cortesi, A.
|
|
2017
|
123 |
S1 |
p. S21-
1 p.
|
artikel
|
| 1592 |
PV-0508: Prognostic significance of PD-L1 expression in patients with head and neck squamous cell carcinoma
|
Peng, C.
|
|
2017
|
123 |
S1 |
p. S267-S268
2 p.
|
artikel
|
| 1593 |
PV-0553: Prognostic significance of Testosteron Level in prostate carcinoma patients treated with TAB and RT
|
Ozyigit, G.
|
|
2017
|
123 |
S1 |
p. S295-
1 p.
|
artikel
|
| 1594 |
PV-0459: Prostate CBCT dose optimization : from an iterative mAs reduction to a sytematic exposure reduction
|
Jaegle, E.
|
|
2017
|
123 |
S1 |
p. S244-S245
2 p.
|
artikel
|
| 1595 |
PV-0551: PSMA PET/CT vs MRI for GTV delineation in prostate cancer: a comparison with histology
|
Zamboglou, C.
|
|
2017
|
123 |
S1 |
p. S294-
1 p.
|
artikel
|
| 1596 |
PV-0286: Quantifying registration uncertainties in image-based data mining
|
Vasquez Osorio, E.M.
|
|
2017
|
123 |
S1 |
p. S150-S151
2 p.
|
artikel
|
| 1597 |
PV-0091: Quantifying the Gap Between Radiotherapy in the Elderly and the Demand for Age-Agnostic Treatment
|
Mee, T.
|
|
2017
|
123 |
S1 |
p. S46-S47
2 p.
|
artikel
|
| 1598 |
PV-0184: Quantitative study on position margin in Intraluminal Brachytherapy Planning for lung treatment
|
Kong, C.W.
|
|
2017
|
123 |
S1 |
p. S94-
1 p.
|
artikel
|
| 1599 |
PV-0043: Radiotherapy to the mediastinum in Hodgkin's lymphoma: Is B-VMAT the only arc solution?
|
Hanna, C.
|
|
2017
|
123 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 1600 |
PV-0322: Rapid Early Response of Gastroesophageal Junction Tumors During Real-time MRI-Guided Radiotherapy
|
Musunuru, H.
|
|
2017
|
123 |
S1 |
p. S168-S169
2 p.
|
artikel
|
| 1601 |
PV-0049: Recurrent skull base and extra-cranial chordoma following proton therapy: clinical outcomes
|
Kountouri, M.
|
|
2017
|
123 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 1602 |
PV-0133: Re-irradiation of pelvic recurrence of rectal cancer: Developing an adaptive plan selection strategy
|
Nyvang, L.
|
|
2017
|
123 |
S1 |
p. S63-S64
2 p.
|
artikel
|
| 1603 |
PV-0089: Relation between pain control and bone mineral density change in bone metastases
|
Kobayashi, H.
|
|
2017
|
123 |
S1 |
p. S45-S46
2 p.
|
artikel
|
| 1604 |
PV-0185: Retina dose as risk factor for worse visual outcome in 106Ru plaque brachytherapy of uveal melanoma
|
Heilemann, G.
|
|
2017
|
123 |
S1 |
p. S94-S95
2 p.
|
artikel
|
| 1605 |
PV-0189: Ring applicator source path determination using a high resolution ionisation chamber array
|
Gainey, M.
|
|
2017
|
123 |
S1 |
p. S97-
1 p.
|
artikel
|
| 1606 |
PV-0135: Short tangential arcs in VMAT based breast and chest wall radiotherapy planning
|
Munshi, A.
|
|
2017
|
123 |
S1 |
p. S64-
1 p.
|
artikel
|
| 1607 |
PV-0187: Source dwell time and transit time measurement for a HDR afterloading unit
|
Chiu, T.L.
|
|
2017
|
123 |
S1 |
p. S95-S96
2 p.
|
artikel
|
| 1608 |
PV-0234: SPECT-CT visualization of axillary lymph nodes in breast cancer: the guide for radiotherapy planning
|
Novikov, S.
|
|
2017
|
123 |
S1 |
p. S117-S118
2 p.
|
artikel
|
| 1609 |
PV-0320: Stereotactic body radiotherapy for liver metastases based on functional treatment planning
|
Fode, M.M.
|
|
2017
|
123 |
S1 |
p. S166-S167
2 p.
|
artikel
|
| 1610 |
PV-0190: The analysis of prostate cancer with median lobe hyperplasia treated I-125 brachytherapy
|
Muraki, K.
|
|
2017
|
123 |
S1 |
p. S97-S98
2 p.
|
artikel
|
| 1611 |
PV-0327: The effect of postoperative complications on Quality of Life in elderly rectal cancer patients
|
Couwenberg, A.M.
|
|
2017
|
123 |
S1 |
p. S171-S172
2 p.
|
artikel
|
| 1612 |
PV-0419: The impact that geometric variability in ionization chamber construction has on kQQo
|
Puxeu Vaqué, J.
|
|
2017
|
123 |
S1 |
p. S220-S221
2 p.
|
artikel
|
| 1613 |
PV-0369: The potential of hyperpolarized 13C MRS to monitor the effect of vascular disrupting agents
|
Iversen, A.
|
|
2017
|
123 |
S1 |
p. S199-
1 p.
|
artikel
|
| 1614 |
PV-0090: The risk of myelopathy after reirradiation of the spinal cord
|
Hiul Suppli, M.
|
|
2017
|
123 |
S1 |
p. S46-
1 p.
|
artikel
|
| 1615 |
PV-0548: The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: a pooled analysis
|
Qu, M.X.
|
|
2017
|
123 |
S1 |
p. S292-
1 p.
|
artikel
|
| 1616 |
PV-0326: Time to surgery and pCR after neoadjuvant CRT in rectal cancer: a population study on 2113 patients
|
Macchia, G.
|
|
2017
|
123 |
S1 |
p. S171-
1 p.
|
artikel
|
| 1617 |
PV-0325: Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma
|
Fokas, E.
|
|
2017
|
123 |
S1 |
p. S170-S171
2 p.
|
artikel
|
| 1618 |
PV-0552: Urethra-sparing SBRT for prostate cancer: acute toxicity results from a randomized phase II trial
|
Zilli, T.
|
|
2017
|
123 |
S1 |
p. S295-
1 p.
|
artikel
|
| 1619 |
PV-0238: Use of Stereotactic Ablative Radiotherapy in Non-Small Cell Lung Cancer Measuring 5 cm or More
|
Tekatli, H.
|
|
2017
|
123 |
S1 |
p. S119-S120
2 p.
|
artikel
|
| 1620 |
PV-0285: Using a surface scanner for positioning of pelvic patients - can X-ray images be omitted?
|
Thomsen, J.B.
|
|
2017
|
123 |
S1 |
p. S149-S150
2 p.
|
artikel
|
| 1621 |
PV-0417: Validation of an analytical peripheral photon dose model for FFF modality
|
G arcia-Hernandez, M.T.
|
|
2017
|
123 |
S1 |
p. S220-
1 p.
|
artikel
|
| 1622 |
PV-0137: Validation of fast motion-including dose reconstruction for proton scanning therapy in the liver
|
Colvill, E.
|
|
2017
|
123 |
S1 |
p. S66-
1 p.
|
artikel
|
| 1623 |
PV-0239: Validation of lung cancer survival models in a clinical routine SBRT population
|
Van Soest, J.
|
|
2017
|
123 |
S1 |
p. S120-
1 p.
|
artikel
|
| 1624 |
PV-0415: Verification of pre-treatment DVH measurements for individual plan QA
|
Stroom, J.
|
|
2017
|
123 |
S1 |
p. S218-S219
2 p.
|
artikel
|
| 1625 |
PV-0456: Volumetric Modulated Arc Therapy for patients with bilateral breast cancer
|
Lutjeboer, S.
|
|
2017
|
123 |
S1 |
p. S242-S243
2 p.
|
artikel
|
| 1626 |
PV-0047: Whole lung irradiation in patients with osteosarcoma and Ewing sarcoma: a systematic review
|
Ronchi, L.
|
|
2017
|
123 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 1627 |
SP-0012: Abscopal responses in metastatic non-small cell lung cancer (NSCLC): a phase II study of combined radiotherapy and ipilimumab
|
Formenti, S.
|
|
2017
|
123 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 1628 |
SP-0338: Access to radiotherapy: cancer-specific approaches to a global problem
|
Rodin, D.
|
|
2017
|
123 |
S1 |
p. S177-
1 p.
|
artikel
|
| 1629 |
SP-0405: Adaptive strategies to account for anatomical changes
|
Sonke, J.J.
|
|
2017
|
123 |
S1 |
p. S215-
1 p.
|
artikel
|
| 1630 |
SP-0406: Adaptive strategies to account for functional changes
|
Toma-Dasu, I.
|
|
2017
|
123 |
S1 |
p. S215-S216
2 p.
|
artikel
|
| 1631 |
SP-0113: Added value of mechanical ventilation in the treatment of moving tumors with photon and proton therapies
|
Geets, X.
|
|
2017
|
123 |
S1 |
p. S54-S55
2 p.
|
artikel
|
| 1632 |
SP-0299: Against the motion
|
Lomax, A.
|
|
2017
|
123 |
S1 |
p. S154-
1 p.
|
artikel
|
| 1633 |
SP-0249: An Overview of Two Radiotherapy Quality Initiatives in Canada
|
Brundage, M.D.
|
|
2017
|
123 |
S1 |
p. S125-S126
2 p.
|
artikel
|
| 1634 |
SP-0408: ART in lung cancer: when and for whom?
|
Berkovic, P.
|
|
2017
|
123 |
S1 |
p. S216-
1 p.
|
artikel
|
| 1635 |
SP-0169: A small animal tumour model for low-energy laser-accelerated particles
|
Pawelke, J.
|
|
2017
|
123 |
S1 |
p. S87-
1 p.
|
artikel
|
| 1636 |
SP-0196: Automated planning, knowledge-based planning and other novelties in treatment planning - how do they work and perform?
|
Heijmen, B.
|
|
2017
|
123 |
S1 |
p. S101-
1 p.
|
artikel
|
| 1637 |
SP-0212: Automatic image segmentation and structure evaluation for on-line adaptive RT
|
Mutic, S.
|
|
2017
|
123 |
S1 |
p. S107-
1 p.
|
artikel
|
| 1638 |
SP-0559: Basics, implementations, applications and limitations of Monte Carlo dose calculation algorithms
|
Verhaegen, F.
|
|
2017
|
123 |
S1 |
p. S299-
1 p.
|
artikel
|
| 1639 |
SP-0078: Best of both worlds: can novel pathways be targeted for reduced gut toxicity but improved tumour response?
|
Olcina, M.M.
|
|
2017
|
123 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 1640 |
SP-0145: Biological rationale and clinical evidence
|
Ost, P.
|
|
2017
|
123 |
S1 |
p. S71-
1 p.
|
artikel
|
| 1641 |
SP-0079: Bowel radiation injury: complexity of the pathophysiology and promises of cell and tissue engineering
|
Moussa, L.
|
|
2017
|
123 |
S1 |
p. S41-
1 p.
|
artikel
|
| 1642 |
SP-0224: Brachytherapy for bladder/prostate rhabdomyosarcoma: clinical outcome and functional results
|
Chargari, C.
|
|
2017
|
123 |
S1 |
p. S112-
1 p.
|
artikel
|
| 1643 |
SP-0095: Brachytherapy physics developments: Look back in anger, grateful, and with hope
|
Venselaar, J.
|
|
2017
|
123 |
S1 |
p. S48-S49
2 p.
|
artikel
|
| 1644 |
SP-0562: Breast cancer
|
Kunkler, I.
|
|
2017
|
123 |
S1 |
p. S300-S301
2 p.
|
artikel
|
| 1645 |
SP-0197: Building of NTCP models that contain non-dosimetric parameters
|
Rancati, T.
|
|
2017
|
123 |
S1 |
p. S101-
1 p.
|
artikel
|
| 1646 |
SP-0396: Can we perform RCTs evaluating MR guided radiotherapy?
|
Valentini, V.
|
|
2017
|
123 |
S1 |
p. S211-
1 p.
|
artikel
|
| 1647 |
SP-0005: Cavity Theory: separating the facts from the myths
|
Nahum, A.
|
|
2017
|
123 |
S1 |
p. S1-
1 p.
|
artikel
|
| 1648 |
SP-0499: "Cervical cancer: literature overview and discussion of clinical case"
|
Motisi, L.
|
|
2017
|
123 |
S1 |
p. S264-
1 p.
|
artikel
|
| 1649 |
SP-0498: Cervical cancer: literature overview and discussion of clinical case
|
Bolm, L.
|
|
2017
|
123 |
S1 |
p. S264-
1 p.
|
artikel
|
| 1650 |
SP-0395: Challenges associated with MR guided radiotherapy
|
Jaffray, D.
|
|
2017
|
123 |
S1 |
p. S211-
1 p.
|
artikel
|
| 1651 |
SP-0572: Circulating tumour DNA, a new tool for the early detection of poor outcome
|
Bidard, F.C.
|
|
2017
|
123 |
S1 |
p. S304-
1 p.
|
artikel
|
| 1652 |
SP-0097: Clinical approach to abscopal effects
|
Lara Jimenez, P.C.
|
|
2017
|
123 |
S1 |
p. S49-
1 p.
|
artikel
|
| 1653 |
SP-0381: Clinical challenges we currently face
|
Troost, E.
|
|
2017
|
123 |
S1 |
p. S206-
1 p.
|
artikel
|
| 1654 |
SP-0593: Clinical commissioning of MR guided treatment systems
|
Green, O.
|
|
2017
|
123 |
S1 |
p. S311-
1 p.
|
artikel
|
| 1655 |
SP-0556: Clinical evidence for hypofractionation in prostate cancer what is the optimum?
|
Blanchard, P.
|
|
2017
|
123 |
S1 |
p. S298-
1 p.
|
artikel
|
| 1656 |
SP-0211: Clinical implementation of coverage probability planning in cervix cancer
|
Lindegaard, J.C.
|
|
2017
|
123 |
S1 |
p. S106-S107
2 p.
|
artikel
|
| 1657 |
SP-0393: Clinical opportunities with MR guided external beam RT
|
Mook, S.
|
|
2017
|
123 |
S1 |
p. S210-S211
2 p.
|
artikel
|
| 1658 |
SP-0096: Cognitive perspective in the radiation oncology physics domain
|
Valentini, V.
|
|
2017
|
123 |
S1 |
p. S49-
1 p.
|
artikel
|
| 1659 |
SP-0519: Collecting PROs in clinical practice to assess radiotherapy toxicity and develop normal tissue complication probability models
|
Gilbert, A.
|
|
2017
|
123 |
S1 |
p. S275-
1 p.
|
artikel
|
| 1660 |
SP-0200: Commissioning of dose calculations in brachytherapy TPS
|
Steenhuijsen, J.
|
|
2017
|
123 |
S1 |
p. S102-
1 p.
|
artikel
|
| 1661 |
SP-0336: Costs and needs of radiotherapy: a regional perspective
|
Zubizarreta - zubi, E.H.
|
|
2017
|
123 |
S1 |
p. S176-S177
2 p.
|
artikel
|
| 1662 |
SP-0023: CT image quality: Using a model observer for clinically relevant optimisation
|
Ryckx, N.
|
|
2017
|
123 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 1663 |
SP-0058: Current status and future perspective of response adaptation
|
Zips, D.
|
|
2017
|
123 |
S1 |
p. S28-
1 p.
|
artikel
|
| 1664 |
SP-0022: Current status and potential of dual energy and spectral CT
|
Andersson, J.
|
|
2017
|
123 |
S1 |
p. S7-
1 p.
|
artikel
|
| 1665 |
SP-0204: Decision support systems and shared decision making
|
Gambacorta, M.A.
|
|
2017
|
123 |
S1 |
p. S103-
1 p.
|
artikel
|
| 1666 |
SP-0311: Deformable registration for dose summation
|
Tanderup, K.
|
|
2017
|
123 |
S1 |
p. S160-S161
2 p.
|
artikel
|
| 1667 |
SP-0404: Development and Clinical Implementation of Image Registration and Dose Accumulation
|
Brock, K.
|
|
2017
|
123 |
S1 |
p. S215-
1 p.
|
artikel
|
| 1668 |
SP-0208: Development of procedures for safe clinical application of plan-of-the-day adaptive radiotherapy
|
Quint, S.
|
|
2017
|
123 |
S1 |
p. S105-
1 p.
|
artikel
|
| 1669 |
SP-0577: Developments in head and neck toxicity data, models, and treatment optimisation
|
Van Der Schaaf, A.
|
|
2017
|
123 |
S1 |
p. S306-
1 p.
|
artikel
|
| 1670 |
SP-0518: Differences between PRO and clinician reported morbidity and associations to clinical outcome
|
Kirchheiner, K.
|
|
2017
|
123 |
S1 |
p. S274-S275
2 p.
|
artikel
|
| 1671 |
SP-0470: Does radiotherapy still have a role in the management of pancreatic cancer?
|
Fokas, E.
|
|
2017
|
123 |
S1 |
p. S249-S250
2 p.
|
artikel
|
| 1672 |
SP-0587: Dose gradients: the effect of high doses inside the CTV comparing boost brachytherapy with SIB
|
Baltas, D.
|
|
2017
|
123 |
S1 |
p. S309-
1 p.
|
artikel
|
| 1673 |
SP-0207: Do we have the tools for safe application of adaptive radiotherapy?
|
Hysing, L.B.
|
|
2017
|
123 |
S1 |
p. S104-S105
2 p.
|
artikel
|
| 1674 |
SP-0247: Driving Radiotherapy Quality Improvement: The Canadian Experience
|
Milosevic, M.
|
|
2017
|
123 |
S1 |
p. S125-
1 p.
|
artikel
|
| 1675 |
SP-0201: E-health and Personalised Radiation Oncology: cloud technologies and advanced sensing
|
Kyriazakos, S.
|
|
2017
|
123 |
S1 |
p. S102-
1 p.
|
artikel
|
| 1676 |
SP-0410: ERC grants - how to succeed
|
Vooijs, M.
|
|
2017
|
123 |
S1 |
p. S217-
1 p.
|
artikel
|
| 1677 |
SP-0412: ESTRO educational grant - if you don't try, you won't win
|
Spalek, M.
|
|
2017
|
123 |
S1 |
p. S217-
1 p.
|
artikel
|
| 1678 |
SP-0411: ESTRO educational grants and mobility grants
|
Vozenin, M.C.
|
|
2017
|
123 |
S1 |
p. S217-
1 p.
|
artikel
|
| 1679 |
SP-0413: ESTRO mobility grant - establishing intravital brain imaging in preclinical models
|
Birch, J.
|
|
2017
|
123 |
S1 |
p. S217-S218
2 p.
|
artikel
|
| 1680 |
SP-0027: Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery:QUIRO-DEGRO trial
|
Zabel-du Bois, A.
|
|
2017
|
123 |
S1 |
p. S9-
1 p.
|
artikel
|
| 1681 |
SP-0414: Experience with the ESTRO mobility grant; proton irradiation of a 3D dosimeter
|
Høye, E.M.
|
|
2017
|
123 |
S1 |
p. S218-
1 p.
|
artikel
|
| 1682 |
SP-0566: External beam partial breast irradiation: changing patient selection based on current evidence
|
Meattini, I.
|
|
2017
|
123 |
S1 |
p. S302-S303
2 p.
|
artikel
|
| 1683 |
SP-0557: Extracellular vesicles in radiation oncology
|
Røe Redalen, K.
|
|
2017
|
123 |
S1 |
p. S298-S299
2 p.
|
artikel
|
| 1684 |
SP-0584: Extreme hypofractionation - the future of prostate care or repeating past mistakes?
|
Loblaw, A.
|
|
2017
|
123 |
S1 |
p. S309-
1 p.
|
artikel
|
| 1685 |
SP-0385: Focus on lung cancer: What a radiotherapy department should offer their patients
|
Guckenberger, M.
|
|
2017
|
123 |
S1 |
p. S207-
1 p.
|
artikel
|
| 1686 |
SP-0298: For the motion
|
Raaymakers, B.
|
|
2017
|
123 |
S1 |
p. S154-
1 p.
|
artikel
|
| 1687 |
SP-0473: From Genomics and Radiogenomics data to a better RT
|
Vega, A.
|
|
2017
|
123 |
S1 |
p. S251-
1 p.
|
artikel
|
| 1688 |
SP-0474: From radiotherapy & dosimetry data to better plans
|
Hoogeman, M.
|
|
2017
|
123 |
S1 |
p. S251-S252
2 p.
|
artikel
|
| 1689 |
SP-0337: “From the ground up” - tackling challenges at the country level
|
Yap, M.L.
|
|
2017
|
123 |
S1 |
p. S177-
1 p.
|
artikel
|
| 1690 |
SP-0109: Functional imaging as biomarker for toxicity response
|
Cao, Y.
|
|
2017
|
123 |
S1 |
p. S53-
1 p.
|
artikel
|
| 1691 |
SP-0007: Gene editing: How this technique can be used to study radiation responses?
|
Marignol, L.
|
|
2017
|
123 |
S1 |
p. S1-
1 p.
|
artikel
|
| 1692 |
SP-0401: Grid therapy: past, present, and future
|
Siegbahn, A.
|
|
2017
|
123 |
S1 |
p. S213-S214
2 p.
|
artikel
|
| 1693 |
SP-0335: GTFRCC: where to go from here?
|
Lievens, Y.
|
|
2017
|
123 |
S1 |
p. S176-
1 p.
|
artikel
|
| 1694 |
SP-0294: Health Technology Assessment: what’s in a word?
|
Aggarwal, A.
|
|
2017
|
123 |
S1 |
p. S152-
1 p.
|
artikel
|
| 1695 |
SP-0025: High tech approaches for curative treatment, when is enough enough?
|
Kazmierska, J.
|
|
2017
|
123 |
S1 |
p. S8-
1 p.
|
artikel
|
| 1696 |
SP-0006: High tech or low tech for metastatic disease, how does one decide and what is the cost-benefit?
|
Van der Linden, Y.
|
|
2017
|
123 |
S1 |
p. S1-
1 p.
|
artikel
|
| 1697 |
SP-0380: How to reduce range uncertainties
|
Knopf, A.
|
|
2017
|
123 |
S1 |
p. S205-
1 p.
|
artikel
|
| 1698 |
SP-0216: How to start up a proton therapy department - the point of view of a RTT
|
Furberg, M.
|
|
2017
|
123 |
S1 |
p. S108-S109
2 p.
|
artikel
|
| 1699 |
SP-0386: How to write a research proposal for a grant?
|
Lambin, P.
|
|
2017
|
123 |
S1 |
p. S207-S208
2 p.
|
artikel
|
| 1700 |
SP-0585: Hypofractionation in prostate cancer: a word of caution
|
Bentzen, S.
|
|
2017
|
123 |
S1 |
p. S309-
1 p.
|
artikel
|
| 1701 |
SP-0312: Imaging and fusion techniques for focal brachytherapy
|
Beaulieu, L.
|
|
2017
|
123 |
S1 |
p. S161-
1 p.
|
artikel
|
| 1702 |
SP-0389: Imaging and molecular profiles to predict response to chemoradiotherapy: where do we stand?
|
Haustermans, K.
|
|
2017
|
123 |
S1 |
p. S209-
1 p.
|
artikel
|
| 1703 |
SP-0433: Imaging biobanks: challenges and opportunities
|
Van der Lugt, A.
|
|
2017
|
123 |
S1 |
p. S228-
1 p.
|
artikel
|
| 1704 |
SP-0111: Imaging biomarkers to predict and early assess the response to radiation therapy. Potential impact of studies in small animals
|
Gallez, B.
|
|
2017
|
123 |
S1 |
p. S54-
1 p.
|
artikel
|
| 1705 |
SP-0110: Imaging tumour response to neoadjuvant treatment in GI tumours
|
Meijer, G.
|
|
2017
|
123 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 1706 |
SP-0112: Immobilising the patient to be as comfortable as possible. A general overview
|
Osztavics, A.
|
|
2017
|
123 |
S1 |
p. S54-
1 p.
|
artikel
|
| 1707 |
SP-0528: Immunobiology of gastro-intestinal tumours
|
Huber, P.
|
|
2017
|
123 |
S1 |
p. S279-
1 p.
|
artikel
|
| 1708 |
SP-0002: Immunotherapy
|
Coukos, G.
|
|
2017
|
123 |
S1 |
p. S1-
1 p.
|
artikel
|
| 1709 |
SP-0409: Improvements in physics, DIBH in lung
|
Josipovic, M.
|
|
2017
|
123 |
S1 |
p. S216-S217
2 p.
|
artikel
|
| 1710 |
SP-0203: Innovative clinical trial designs for Personalised Radiation Oncology
|
Brown, S.
|
|
2017
|
123 |
S1 |
p. S103-
1 p.
|
artikel
|
| 1711 |
SP-0014: In situ Cancer Vaccines: Tumor destruction and immune stimulation for local and systemic tumor control
|
Adema, G.
|
|
2017
|
123 |
S1 |
p. S4-
1 p.
|
artikel
|
| 1712 |
SP-0020: Integrating CBCT in ion beam therapy: challenges and opportunities beyond anatomical guidance
|
Teo, K.
|
|
2017
|
123 |
S1 |
p. S6-
1 p.
|
artikel
|
| 1713 |
SP-0202: Integration and analysis of complex data for Personalised Radiation Oncology
|
Dekker, A.
|
|
2017
|
123 |
S1 |
p. S102-S103
2 p.
|
artikel
|
| 1714 |
SP-0147: Interpretation and management of oligometastases
|
Onishi, H.
|
|
2017
|
123 |
S1 |
p. S71-S72
2 p.
|
artikel
|
| 1715 |
SP-0225: Intraoperative HDR brachytherapy for pediatric cancers
|
Wolden, S.
|
|
2017
|
123 |
S1 |
p. S112-
1 p.
|
artikel
|
| 1716 |
SP-0122: Introducing the Brachy-HERO initiative
|
Tan, L.T.
|
|
2017
|
123 |
S1 |
p. S57-
1 p.
|
artikel
|
| 1717 |
SP-0495: Introduction of FALCON (Fellowship in Anatomic delineation and CONtouring) online contouring system as a tool for e-learning
|
Eriksen, J.G.
|
|
2017
|
123 |
S1 |
p. S263-
1 p.
|
artikel
|
| 1718 |
SP-0564: Lung
|
Van Loon, J.
|
|
2017
|
123 |
S1 |
p. S301-S302
2 p.
|
artikel
|
| 1719 |
SP-0596: Machine learning and bioinformatics approaches to combine imaging with non-imaging data for outcome prediction
|
Gevaert, O.
|
|
2017
|
123 |
S1 |
p. S313-
1 p.
|
artikel
|
| 1720 |
SP-0057: Mechanisms and biomarkers of tumour response heterogeneity
|
Chopra, S.
|
|
2017
|
123 |
S1 |
p. S28-
1 p.
|
artikel
|
| 1721 |
SP-0107: Mechanisms and Models of Particle Relative Biological Effectiveness (RBE)
|
Carlson, D.J.
|
|
2017
|
123 |
S1 |
p. S52-S53
2 p.
|
artikel
|
| 1722 |
SP-0308: Metabolic and functional MRI integration for glioblastoma dose-painting trial
|
Laprie, A.
|
|
2017
|
123 |
S1 |
p. S160-
1 p.
|
artikel
|
| 1723 |
SP-0297: Method of development of ESMO Magnitude of Clinical Benefit applicable for radiotherapy?
|
De Vries, E.G.E.
|
|
2017
|
123 |
S1 |
p. S153-S154
2 p.
|
artikel
|
| 1724 |
SP-0288: Mind the gaps!
|
Lievens, Y.
|
|
2017
|
123 |
S1 |
p. S151-
1 p.
|
artikel
|
| 1725 |
SP-0210: Minimax robust optimisation applied to IMPT for oropharyngeal tumours
|
Van de Water, S.
|
|
2017
|
123 |
S1 |
p. S105-S106
2 p.
|
artikel
|
| 1726 |
SP-0574: MLC tracking: from bench to bedside
|
Fast, M.
|
|
2017
|
123 |
S1 |
p. S305-
1 p.
|
artikel
|
| 1727 |
SP-0595: Modeling the interplay among volume, vascularization and radio-sensitivity in cervical cancer exploiting 3D-Doppler data
|
Belfatto, A.
|
|
2017
|
123 |
S1 |
p. S312-S313
2 p.
|
artikel
|
| 1728 |
SP-0583: Moderate hypofractionation in prostate cancer: what have we learnt from phase 3 trials
|
Dearnaley, D.P.
|
|
2017
|
123 |
S1 |
p. S308-S309
2 p.
|
artikel
|
| 1729 |
SP-0291: Modern biomarkers for therapeutic strategy: radiation dose or volume modification
|
Krause, M.
|
|
2017
|
123 |
S1 |
p. S152-
1 p.
|
artikel
|
| 1730 |
SP-0589: Molecular mechanisms of radiation-induced in situ tumor vaccination
|
Demaria, S.
|
|
2017
|
123 |
S1 |
p. S310-
1 p.
|
artikel
|
| 1731 |
SP-0290: More than one century after the serendipitous discovery of X-rays, there is still a bright future for radiation oncology …
|
Bourhis, J.
|
|
2017
|
123 |
S1 |
p. S151-S152
2 p.
|
artikel
|
| 1732 |
SP-0114: Motion of liver tumours using Active Breathing Control: keeping the margins small and the patient comfortable
|
Mast, M.E.
|
|
2017
|
123 |
S1 |
p. S55-
1 p.
|
artikel
|
| 1733 |
SP-0575: Motions models and tracking using MR
|
Tijssen, R.
|
|
2017
|
123 |
S1 |
p. S305-S306
2 p.
|
artikel
|
| 1734 |
SP-0475: Moving Big Data into Clinical Practice – A positive outlook
|
Vinod, S.
|
|
2017
|
123 |
S1 |
p. S252-
1 p.
|
artikel
|
| 1735 |
SP-0394: MR guided brachytherapy - successes and potential future developments
|
Hoskin, P.
|
|
2017
|
123 |
S1 |
p. S211-
1 p.
|
artikel
|
| 1736 |
SP-0003: MRI for RO physicists: what is what? QA geometrical distortions
|
Paulson, E.
|
|
2017
|
123 |
S1 |
p. S1-
1 p.
|
artikel
|
| 1737 |
SP-0307: Multi-parametric functional PET/MR imaging for RT individualisation
|
Thorwarth, D.
|
|
2017
|
123 |
S1 |
p. S159-S160
2 p.
|
artikel
|
| 1738 |
SP-0021: New horizons in probabilistic and robust treatment planning in particle therapy
|
Alber, M.
|
|
2017
|
123 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 1739 |
SP-0108: New horizons in radiobiology: from Relative Biological Effectiveness to “new biology”
|
Durante, M.
|
|
2017
|
123 |
S1 |
p. S53-
1 p.
|
artikel
|
| 1740 |
SP-0579: New NTCP data in the pelvic area
|
Fiorino, C.
|
|
2017
|
123 |
S1 |
p. S306-S307
2 p.
|
artikel
|
| 1741 |
SP-0578: New NTCP data in the thoracic region: probing 'dark toxicity'
|
Deasy, J.
|
|
2017
|
123 |
S1 |
p. S306-
1 p.
|
artikel
|
| 1742 |
SP-0555: New radiotherapeutic horizons in soft tissue sarcoma treatment
|
Haas, R.
|
|
2017
|
123 |
S1 |
p. S298-
1 p.
|
artikel
|
| 1743 |
SP-0218: Novel approaches in the study of bladder cancer
|
Kiltie, A.
|
|
2017
|
123 |
S1 |
p. S109-S110
2 p.
|
artikel
|
| 1744 |
SP-0435: Novel developments in molecular targeting of prostate cancer
|
Bristow, R.
|
|
2017
|
123 |
S1 |
p. S229-
1 p.
|
artikel
|
| 1745 |
SP-0590: Novel developments in paediatric cancer
|
McCabe, M.G.
|
|
2017
|
123 |
S1 |
p. S310-S311
2 p.
|
artikel
|
| 1746 |
SP-0398: Novel developments in the radiobiology of HPV-positive head and neck tumours
|
Nuyts, S.
|
|
2017
|
123 |
S1 |
p. S212-
1 p.
|
artikel
|
| 1747 |
SP-0170: Novel models in particle biology research
|
Van Luijk, P.
|
|
2017
|
123 |
S1 |
p. S87-
1 p.
|
artikel
|
| 1748 |
SP-0100: Oligometastastic cancer: a therapeutic challenge
|
Van der Hoeven, K.
|
|
2017
|
123 |
S1 |
p. S50-
1 p.
|
artikel
|
| 1749 |
SP-0146: Oligometastatic disease: Radiophysics implementation and pitfalls
|
Verellen, D.
|
|
2017
|
123 |
S1 |
p. S71-
1 p.
|
artikel
|
| 1750 |
SP-0214: Online tumour tracking - technology and quality assurance
|
Colvill, E.
|
|
2017
|
123 |
S1 |
p. S107-S108
2 p.
|
artikel
|
| 1751 |
SP-0033: Optical and tracking technologies for navigation in brachytherapy
|
Weersink, R.
|
|
2017
|
123 |
S1 |
p. S11-
1 p.
|
artikel
|
| 1752 |
SP-0124: Optimal utilisation of brachytherapy in Europecan it be measured?
|
Borras, J.M.
|
|
2017
|
123 |
S1 |
p. S57-
1 p.
|
artikel
|
| 1753 |
SP-0219: Optimising the output of preclinical lung models to optimize the chances of succes into the clinic
|
Deutsch, E.
|
|
2017
|
123 |
S1 |
p. S110-
1 p.
|
artikel
|
| 1754 |
SP-0191: Optimizing the Treatment of HPV-related Oropharyngeal Cancer: the difficult journey back
|
O'Sullivan, B.
|
|
2017
|
123 |
S1 |
p. S98-
1 p.
|
artikel
|
| 1755 |
SP-0026: Optimizing the workflow of palliative treatment using Lean Six Sigma methodology
|
Kamphuis, M.
|
|
2017
|
123 |
S1 |
p. S8-
1 p.
|
artikel
|
| 1756 |
SP-0388: Organ preservation by optimised radiotherapy: ready for prime time?
|
Beets, G.
|
|
2017
|
123 |
S1 |
p. S208-S209
2 p.
|
artikel
|
| 1757 |
SP-0392: ‘Paediatric’ brain tumours in adults
|
Seidel, C.
|
|
2017
|
123 |
S1 |
p. S210-
1 p.
|
artikel
|
| 1758 |
SP-0567: Partial breast irradiation with brachytherapy: changing patient selection based on current evidence
|
Polgár, C.
|
|
2017
|
123 |
S1 |
p. S303-
1 p.
|
artikel
|
| 1759 |
SP-0315: Partial breast radiotherapy after breast conservation for breast cancer: early results from the randomised DBCG PBI trial
|
Offersen, B.
|
|
2017
|
123 |
S1 |
p. S163-S164
2 p.
|
artikel
|
| 1760 |
SP-0314: Partial breast radiotherapy after breast conservation: 5 year outcomes from the IMPORT LOW (CRUK/06/003) phase III trial
|
Coles, C.
|
|
2017
|
123 |
S1 |
p. S162-S163
2 p.
|
artikel
|
| 1761 |
SP-0198: Particle therapy – how to start up and carry out daily clinical practice
|
Hentschel, H.
|
|
2017
|
123 |
S1 |
p. S101-
1 p.
|
artikel
|
| 1762 |
SP-0580: Patient education - tools to improve patient positioning
|
Hansen, H.
|
|
2017
|
123 |
S1 |
p. S307-
1 p.
|
artikel
|
| 1763 |
SP-0476: Personalised local and locoregional radiotherapy in breast cancer
|
Tramm, T.
|
|
2017
|
123 |
S1 |
p. S253-
1 p.
|
artikel
|
| 1764 |
SP-0407: PET/CT artefacts for RT planning
|
Santos, A.
|
|
2017
|
123 |
S1 |
p. S216-
1 p.
|
artikel
|
| 1765 |
SP-0029: Pharmacological modulation of cardiac radiation injury
|
Boerma, M.
|
|
2017
|
123 |
S1 |
p. S9-
1 p.
|
artikel
|
| 1766 |
SP-0309: Plan of the day and dose-escalation for bladder cancer (RAIDER Trial)
|
McNair, H.
|
|
2017
|
123 |
S1 |
p. S160-
1 p.
|
artikel
|
| 1767 |
SP-0192: Potential of radiation therapy to convert the tumor into an in situ vaccine
|
Formenti, S.
|
|
2017
|
123 |
S1 |
p. S98-S99
2 p.
|
artikel
|
| 1768 |
SP-0403: Potentials of Cerenkov imaging in radiotherapy
|
Spinelli, A.
|
|
2017
|
123 |
S1 |
p. S214-S215
2 p.
|
artikel
|
| 1769 |
SP-0598: Precision in RT: mission completed!
|
Duffton, A.
|
|
2017
|
123 |
S1 |
p. S313-S314
2 p.
|
artikel
|
| 1770 |
SP-0594: Pre-treatment phantom dosimetry: effects in different phantoms and detectors
|
Van Asselen, B.
|
|
2017
|
123 |
S1 |
p. S311-S312
2 p.
|
artikel
|
| 1771 |
SP-0479: Primary human Lung (stem) cell models to study adverse effects of cancer treatments
|
Vooijs, M.
|
|
2017
|
123 |
S1 |
p. S254-
1 p.
|
artikel
|
| 1772 |
SP-0582: PROMs analysis to improve communication and enhance practice
|
Lemanska, A.
|
|
2017
|
123 |
S1 |
p. S307-S308
2 p.
|
artikel
|
| 1773 |
SP-0520: PROs instruments used in clinical trials
|
Faithfull, S.
|
|
2017
|
123 |
S1 |
p. S275-S276
2 p.
|
artikel
|
| 1774 |
SP-0581: Public knowledge of RT saves lives: the case for RT awareness
|
Naessens, E.
|
|
2017
|
123 |
S1 |
p. S307-
1 p.
|
artikel
|
| 1775 |
SP-0193: Quality improvement in radiotherapy: history, significance and impact of dosimetry audits
|
Izewska, J.
|
|
2017
|
123 |
S1 |
p. S99-
1 p.
|
artikel
|
| 1776 |
SP-0293: Radiation de-escalation strategies in HPV-positive squamous cell carcinoma
|
Giralt, J.
|
|
2017
|
123 |
S1 |
p. S152-
1 p.
|
artikel
|
| 1777 |
SP-0478: Radiation therapy after complete response after primary systemic therapy. Is it needed?
|
Poortmans, P.
|
|
2017
|
123 |
S1 |
p. S253-
1 p.
|
artikel
|
| 1778 |
SP-0469: Radio(chemo)therapy in oesophageal cancer: can we do better?
|
Hulshof, M.
|
|
2017
|
123 |
S1 |
p. S249-
1 p.
|
artikel
|
| 1779 |
SP-0384: Radiomics for physicists – understanding feature extraction, modelling, performance validation and applications of radiomics
|
Walsh, S.
|
|
2017
|
123 |
S1 |
p. S207-
1 p.
|
artikel
|
| 1780 |
SP-0430: Radiomics in radiology, what are the parameters of interest for different imaging modalities?
|
Ahlström, H.
|
|
2017
|
123 |
S1 |
p. S228-
1 p.
|
artikel
|
| 1781 |
SP-0431: Radiomics in radiotherapy. How is it used to personalise treatment and to predict toxicity and/or tumour control
|
Gani, C.
|
|
2017
|
123 |
S1 |
p. S228-
1 p.
|
artikel
|
| 1782 |
SP-0570: Radiopharmaceuticals in pancreatic cancer: imaging and therapy
|
Cornelissen, B.
|
|
2017
|
123 |
S1 |
p. S304-
1 p.
|
artikel
|
| 1783 |
SP-0016: Radiotherapy and immunotherapy combination: paradigm changing or just hype?
|
Dovedi, S.J.
|
|
2017
|
123 |
S1 |
p. S5-
1 p.
|
artikel
|
| 1784 |
SP-0295: Radiotherapy costs: the good, the bad and the ugly
|
Perrier, L.
|
|
2017
|
123 |
S1 |
p. S153-
1 p.
|
artikel
|
| 1785 |
SP-0390: Radiotherapy for low grade glioma in adults in 2017. What’s crazy!
|
Villà Freixa, S.
|
|
2017
|
123 |
S1 |
p. S209-
1 p.
|
artikel
|
| 1786 |
SP-0561: Radiotherapy in elderly rectal cancer patients
|
Nout, R.
|
|
2017
|
123 |
S1 |
p. S300-
1 p.
|
artikel
|
| 1787 |
SP-0563: Radiotherapy in older patients with GBM
|
Minniti, G.
|
|
2017
|
123 |
S1 |
p. S301-
1 p.
|
artikel
|
| 1788 |
SP-0248: Radiotherapy Quality Management and Improvement across Europe: variable approaches, united view
|
Jornet, N.
|
|
2017
|
123 |
S1 |
p. S125-
1 p.
|
artikel
|
| 1789 |
SP-0168: RBE of protons
|
Jones, B.
|
|
2017
|
123 |
S1 |
p. S86-S87
2 p.
|
artikel
|
| 1790 |
SP-0501: Rectal cancer: literature overview
|
Haustermans, K.
|
|
2017
|
123 |
S1 |
p. S264-
1 p.
|
artikel
|
| 1791 |
SP-0500: Rectal cancer: literature overview and discussion of clinical case
|
Barua, I.S.
|
|
2017
|
123 |
S1 |
p. S264-
1 p.
|
artikel
|
| 1792 |
SP-0106: Reducing range uncertainties: new approaches for stopping power determination and in-vivo range verification
|
Parodi, K.
|
|
2017
|
123 |
S1 |
p. S52-
1 p.
|
artikel
|
| 1793 |
SP-0592: Reference dosimetry: getting the basics and calibration right
|
Duane, S.
|
|
2017
|
123 |
S1 |
p. S311-
1 p.
|
artikel
|
| 1794 |
SP-0115: Response of adult neural stem cells to radiation-induced DNA damage
|
Barazzuol, L.
|
|
2017
|
123 |
S1 |
p. S55-
1 p.
|
artikel
|
| 1795 |
SP-0059: Response optimised treatment planning and guidance
|
Vanderstraeten, B.
|
|
2017
|
123 |
S1 |
p. S28-
1 p.
|
artikel
|
| 1796 |
SP-0123: Review of health related quality of life measures with brachytherapy and application to QALY for economic evaluation
|
Kim, H.
|
|
2017
|
123 |
S1 |
p. S57-
1 p.
|
artikel
|
| 1797 |
SP-0310: Rigid registration techniques for different imaging modalities
|
Nesvacil, N.
|
|
2017
|
123 |
S1 |
p. S160-
1 p.
|
artikel
|
| 1798 |
SP-0194: Role of radiotherapy in extranodal lymphomas
|
Specht, L.
|
|
2017
|
123 |
S1 |
p. S100-
1 p.
|
artikel
|
| 1799 |
SP-0497: Role of radiotherapy in the treatment of stage IIIA/pN2 non-small cell lung cancer
|
Jeremic, B.
|
|
2017
|
123 |
S1 |
p. S263-S264
2 p.
|
artikel
|
| 1800 |
SP-0496: Role of radiotherapy in the treatment of stage IIIA/pN2 non-small cell lung cancer
|
Käsmann, L.
|
|
2017
|
123 |
S1 |
p. S263-
1 p.
|
artikel
|
| 1801 |
SP-0560: RTTs roles and responsibilities to support future practice
|
Coffey, M.
|
|
2017
|
123 |
S1 |
p. S299-S300
2 p.
|
artikel
|
| 1802 |
SP-0215: RTTs skills for proton therapy - how and what to include in a learning programme
|
Boejen, A.
|
|
2017
|
123 |
S1 |
p. S108-
1 p.
|
artikel
|
| 1803 |
SP-0148: SBRT for oligometastases
|
Kimura, T.
|
|
2017
|
123 |
S1 |
p. S72-
1 p.
|
artikel
|
| 1804 |
SP-0379: SBRT for spine and non-spine bone metastases: what role in routine practice?
|
Dahele, M.
|
|
2017
|
123 |
S1 |
p. S205-
1 p.
|
artikel
|
| 1805 |
SP-0019: Scaling down proton therapy facilities to fit into photon vaults
|
Bortfeld, T.
|
|
2017
|
123 |
S1 |
p. S6-
1 p.
|
artikel
|
| 1806 |
SP-0480: Secretome as novel target for lung cancer
|
Pruschy, M.
|
|
2017
|
123 |
S1 |
p. S254-
1 p.
|
artikel
|
| 1807 |
SP-0387: Sequence of radiotherapy, chemotherapy, and surgery: current concepts and trials
|
Glynne-Jones, R.
|
|
2017
|
123 |
S1 |
p. S208-
1 p.
|
artikel
|
| 1808 |
SP-0471: Standard treatment in anal cancer: where do we stand and where should we go?
|
Muirhead, R.
|
|
2017
|
123 |
S1 |
p. S250-
1 p.
|
artikel
|
| 1809 |
SP-0383: State of the art and future improvements for in-room cone-beam CT image quality
|
Moseley, D.
|
|
2017
|
123 |
S1 |
p. S206-S207
2 p.
|
artikel
|
| 1810 |
SP-0527: State of the art in colorectal cancer radiobiology
|
Bussink, J.
|
|
2017
|
123 |
S1 |
p. S279-
1 p.
|
artikel
|
| 1811 |
SP-0397: State of the art in head and neck tumour radiobiology
|
O'Sullivan, B.
|
|
2017
|
123 |
S1 |
p. S211-S212
2 p.
|
artikel
|
| 1812 |
SP-0028: State of the art in heart effects
|
Vozenin, M.C.
|
|
2017
|
123 |
S1 |
p. S9-
1 p.
|
artikel
|
| 1813 |
SP-0434: State of the art in prostate tumour radiobiology
|
Peitzsch, C.
|
|
2017
|
123 |
S1 |
p. S229-
1 p.
|
artikel
|
| 1814 |
SP-0378: State of the art multimodality treatment of rectal cancer
|
Rödel, C.
|
|
2017
|
123 |
S1 |
p. S205-
1 p.
|
artikel
|
| 1815 |
SP-0571: State of the art precision medicine for benign and malignant brain tumours
|
Zadeh, G.
|
|
2017
|
123 |
S1 |
p. S304-
1 p.
|
artikel
|
| 1816 |
SP-0402: Strategies for radiosensitization with gold nanoparticles
|
Krishnan, S.
|
|
2017
|
123 |
S1 |
p. S214-
1 p.
|
artikel
|
| 1817 |
SP-0195: Strategies to increase safety in radiation oncology: how to make accidents less likely to occur
|
Scalliet, P.
|
|
2017
|
123 |
S1 |
p. S100-S101
2 p.
|
artikel
|
| 1818 |
SP-0094: Substantial and “for free” improvement of radiotherapy practice in high and low income countries
|
Heijmen, B.
|
|
2017
|
123 |
S1 |
p. S48-
1 p.
|
artikel
|
| 1819 |
SP-0565: Target coverage and dose to organs at risk using different techniques of APBI (EBI, IORT, BT)
|
Marrazzo, L.
|
|
2017
|
123 |
S1 |
p. S302-
1 p.
|
artikel
|
| 1820 |
SP-0008: Target delineation and target definition for Partial Breast Irradiation after closed cavity surgery and oncoplastic surgery
|
Strnad, V.
|
|
2017
|
123 |
S1 |
p. S2-
1 p.
|
artikel
|
| 1821 |
SP-0009: Target delineation and target definition for PBI after open cavity surgery
|
Major, T.
|
|
2017
|
123 |
S1 |
p. S2-
1 p.
|
artikel
|
| 1822 |
SP-0382: Targeting histones and epigenetic mechanisms in radiation biology and oncology
|
Ree, A.H.
|
|
2017
|
123 |
S1 |
p. S206-
1 p.
|
artikel
|
| 1823 |
SP-0223: The AMORE concept and late effects outcome for paediatric brachytherapy
|
Pieters, B.
|
|
2017
|
123 |
S1 |
p. S111-
1 p.
|
artikel
|
| 1824 |
SP-0103: The challenges of targeting tumour heterogeneity in the field of radiation oncology
|
Lambin, P.
|
|
2017
|
123 |
S1 |
p. S51-S52
2 p.
|
artikel
|
| 1825 |
SP-0292: The changing role of head and neck surgeon in HPV-positive oropharyngeal squamous cell carcinoma, or do we still need surgery?
|
Simon, C.
|
|
2017
|
123 |
S1 |
p. S152-
1 p.
|
artikel
|
| 1826 |
SP-0116: The cognitive defects of neonatally irradiated mice are accompanied by changes in adult neurogenesis
|
Tapio, S.
|
|
2017
|
123 |
S1 |
p. S55-
1 p.
|
artikel
|
| 1827 |
SP-0586: The efficacy of IGRT/IMRT simultaneous integrated boost (SIB) in gynaecology and breast
|
Ozsahin, E.M.
|
|
2017
|
123 |
S1 |
p. S309-
1 p.
|
artikel
|
| 1828 |
SP-0167: The ESTRO initiative on biological effects of particle therapy
|
Sørensen, B.S.
|
|
2017
|
123 |
S1 |
p. S86-
1 p.
|
artikel
|
| 1829 |
SP-0010: The gains to be made by combined modality treatment in NSCLC: setting the scene of new possibilities
|
Stuschke, M.
|
|
2017
|
123 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 1830 |
SP-0104: The impact of tumour heterogeneity on radiation therapy outcomes
|
Gerlinger, M.
|
|
2017
|
123 |
S1 |
p. S52-
1 p.
|
artikel
|
| 1831 |
SP-0015: The impact of tumour infiltrating lymphocytes on clinical outcome after (chemo)radiotherapy
|
Galon, J.
|
|
2017
|
123 |
S1 |
p. S4-
1 p.
|
artikel
|
| 1832 |
SP-0024: The potential of new CT technologies for radiotherapy with photons and protons
|
Van Elmpt, W.
|
|
2017
|
123 |
S1 |
p. S8-
1 p.
|
artikel
|
| 1833 |
SP-0472: The pros, cons, process and challenges for achieving better radiotherapy through data -an introduction
|
Holloway, L.C.
|
|
2017
|
123 |
S1 |
p. S250-S251
2 p.
|
artikel
|
| 1834 |
SP-0001: The role of radiotherapy in small cell lung cancer -current status and future developments
|
Dziadziuszko, R.
|
|
2017
|
123 |
S1 |
p. S1-
1 p.
|
artikel
|
| 1835 |
SP-0493: The role of spacers in the era of highly conformal, hypo-fractionated, image guided, adaptive radiotherapy of the prostate
|
Scherer, P.
|
|
2017
|
123 |
S1 |
p. S262-S263
2 p.
|
artikel
|
| 1836 |
SP-0032: The technique for CT/MR guided hepatic implantations
|
Tselis, N.
|
|
2017
|
123 |
S1 |
p. S11-
1 p.
|
artikel
|
| 1837 |
SP-0011: The use of biomarkers for individualized treatment in NSCLC
|
Belderbos, J.
|
|
2017
|
123 |
S1 |
p. S3-
1 p.
|
artikel
|
| 1838 |
SP-0013: The use of novel technologies (e.g. protons) in NSCLC
|
Liao, Z.
|
|
2017
|
123 |
S1 |
p. S4-
1 p.
|
artikel
|
| 1839 |
SP-0199: Three-dimensional cell culture systems
|
Cordes, N.
|
|
2017
|
123 |
S1 |
p. S101-S102
2 p.
|
artikel
|
| 1840 |
SP-0206: Tips and tricks for safe and effective routine clinical application
|
Duprez, F.
|
|
2017
|
123 |
S1 |
p. S104-
1 p.
|
artikel
|
| 1841 |
SP-0597: Tissue classification models for prostate based on imaging and non-imaging data
|
Van der Heide, U.
|
|
2017
|
123 |
S1 |
p. S313-
1 p.
|
artikel
|
| 1842 |
SP-0576: Tracking: present status and what to expect in the near future
|
Ravkilde, T.
|
|
2017
|
123 |
S1 |
p. S306-
1 p.
|
artikel
|
| 1843 |
SP-0213: Ultra-fast treatment planning and dose reconstruction
|
Ziegenhein, P.
|
|
2017
|
123 |
S1 |
p. S107-
1 p.
|
artikel
|
| 1844 |
SP-0432: Uncertainties in imaging -how they should be reported and propagated in prediction models using radiomics
|
Muren, L.
|
|
2017
|
123 |
S1 |
p. S228-
1 p.
|
artikel
|
| 1845 |
SP-0558: Update on molecular radiotherapy
|
Flux, G.
|
|
2017
|
123 |
S1 |
p. S299-
1 p.
|
artikel
|
| 1846 |
SP-0494: Using a MRI-guided radiation therapy system for prostate cancer patients
|
Bohoudi, O.
|
|
2017
|
123 |
S1 |
p. S263-
1 p.
|
artikel
|
| 1847 |
SP-0101: Using heterogeneous brachytherapy dose distributions to target tumour cell heterogeneity
|
Alonzi, R.
|
|
2017
|
123 |
S1 |
p. S50-S51
2 p.
|
artikel
|
| 1848 |
SP-0034: Using multiparametric US to redefine target volumes in brachytherapy
|
Wijkstra, H.
|
|
2017
|
123 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 1849 |
SP-0250: Waiting time in radiotherapy, an overlooked problem
|
Overgaard, J.
|
|
2017
|
123 |
S1 |
p. S126-
1 p.
|
artikel
|
| 1850 |
SP-0492: What are the best ingredients to deliver the optimal radiotherapy for prostate cancer
|
Khoo, V.
|
|
2017
|
123 |
S1 |
p. S262-
1 p.
|
artikel
|
| 1851 |
SP-0205: What evidence is needed to assess cost effectiveness of new technology and how can we get it (easily)?
|
Johannesma, M.
|
|
2017
|
123 |
S1 |
p. S103-S104
2 p.
|
artikel
|
| 1852 |
SP-0209: What is the actual robustness of the plans we deliver in particle therapy and what measures do we take to obtain it
|
Molinelli, S.
|
|
2017
|
123 |
S1 |
p. S105-
1 p.
|
artikel
|
| 1853 |
SP-0099: What is the indication and what is the aim of clinical treatment: radiotherapy
|
Lartigau, E.
|
|
2017
|
123 |
S1 |
p. S50-
1 p.
|
artikel
|
| 1854 |
SP-0098: What is the purpose of surgical metastasectomy and do we achieve it?
|
Treasure, T.
|
|
2017
|
123 |
S1 |
p. S50-
1 p.
|
artikel
|
| 1855 |
SP-0391: What is the role of combined chemoradiotherapy for grade III glioma in adults?
|
Chalmers, A.
|
|
2017
|
123 |
S1 |
p. S209-S210
2 p.
|
artikel
|
| 1856 |
SP-0477: Where should we place radiotherapy: before or after surgery?
|
Boersma, L.J.
|
|
2017
|
123 |
S1 |
p. S253-
1 p.
|
artikel
|
| 1857 |
SP-0588: Why use invasive techniques for boost if IGRT is more comfortable for the patient?
|
Guinot, J.L.
|
|
2017
|
123 |
S1 |
p. S309-S310
2 p.
|
artikel
|
| 1858 |
SP-0217: Workflow in a proton therapy department - real difference from photon therapy?
|
Fellin, F.
|
|
2017
|
123 |
S1 |
p. S109-
1 p.
|
artikel
|
| 1859 |
Title Page
|
|
|
2017
|
123 |
S1 |
p. iii-
1 p.
|
artikel
|
Tijdschrift beschrijving